Åwªï¥úÁ{ ³¢¬P§g ¦Ñ®vÓ¤H¾Ç³N¬ã¨sºô¶ |
°ò¥»¸ê®Æ
|
©ÒÄݨt©Ò¡G
|
Å@²z¨t °òÂå²Õ±Ð¬ã·| ±M¥ô ±Ð±Â ( ¹Å¸q®Õ°Ï )
|
^¤å©m¦W¡G
|
Kuo,Hsing-Chun
|
³Ì°ª¾Ç¾ú¡G
|
¤¤¤sÂå¾Ç¤j¾Ç ¥Í¤Æº[¥Íª«¬ì§Þ¬ã¨s©Ò ³Õ¤h
|
¿ì¤½«Ç¡G
|
ªø©°¬ì§Þ¤j¾Ç ¹Å¸q¤À³¡ A´É 6F 606
|
Ápµ¸¹q¸Ü¡G
|
(05)362-8800#2606
|
¹q¤l¶l¥ó¡G
|
kuohc@mail.cgust.edu.tw
|
±Mªø»â°ì¡G
|
1. ¥Íª«¤Æ¾Ç»PÁ{§É¥Í¤Æ¡@2. ·L¥Íª«§K¬Ì¾Ç»PÁ{§ÉÀËÅç¾Ç¡@3. ³J¥Õ½èÅé¾Ç¡@4. ¤À¤l¸~½F¾Ç¡@
|
¬ã¨s¿³½ì¡G
|
1.¤j¸zª½¸zÀù³J¥Õ½èÅé¬ã¨s¡@2. ¥\¯à©Ê³J¥Õ½èÅé¤èªk±´¯Á¤£¦P¯e¯f¤§¬ã¨s¡@3. °ò¦]ªíÆ[¿ò¶Ç¾÷¨î¤§¬ã¨s¡@4. ¤ÑµMª«µÑ¨ú¯Â¤Æ»P¥\®Ä¶}µo¡@
|
¹ê°È¸gÅç¦Cªí
|
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I ) |
¦~«× | ¾Ç´Á | ¸g¾úÃþ«¬ | ¤u§@¾÷ºc | °_©l¤é´Á | ²×¤î¤é´Á |
095 | 1 | ·~¬É±Mݾ¤u§@¸gÅç | °ê®a½Ã¥Í¬ã¨s°| | 2006/12/29 | 2007/02/28 |
095 | 2 | ·~¬É±Mݾ¤u§@¸gÅç | ªø©°Âå°| | 2007/03/27 | 2008/08/01 |
103 | 1 | ²£¾Ç¦X§@pµe®× | ¸²µå¤ý¥Í§ÞªÑ¥÷¦³¤½¥q | 2014/11/01 | 2016/10/31 |
¬ÛÃöÃÒ·Ó¦Cªí
|
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I ) |
¦~«× | ¾Ç´Á | ÃÒ·ÓÃþ«¬ | ÃÒ·Ó¦WºÙ |
089 | 1 | ±M§Þ°ª´¶¦Ò | Âå¨ÆÀËÅç®vÃÒ®Ñ |
098 | 2 | ¨ä¥L¬ÛÃöÃÒ·Ó | ¦Ò¸Õ¤Î®æÃÒ®Ñ-¤HÅé¸ÕÅç¬ã¨sÛ²z»{ÃÒ¦Ò¸Õ |
098 | 2 | ¨ä¥L¬ÛÃöÃÒ·Ó | ¦Ò¸Õ¤Î®æÃҮѢw¤HÅé¸ÕÅç¬ã¨sÛ²z¶i¶¥»{ÃÒ¦Ò¸Õ |
099 | 2 | ¨ä¥L¬ÛÃöÃÒ·Ó | ¤HÅé¸ÕÅç¬ã¨s¤HûÁ¿²ß¯Z°V½mÃÒ©ú |
±M·~ªA°È¦Cªí
|
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I ) |
¦~«× | ®×¸¹ | ®×¦W | ®Õ¤º/®Õ¥~ | ªA°È¼t°Ó | ªA°È©Ê½è | ¥Í®Ä¤é´Á | ²×¤î¤é´Á |
098 | ¹Å¸qªø©°Âå°|¤ú¬ì | ¨ä¥L¡GÁܽлY°|ºtÁ¿¤Î«ü¾É Stem Cells and Bone Generation | 2010/02/23 | ||||
099 | (99)¹ÅÅ@ªAÃÒ¦r²Ä0020¸¹ | ·P¬VÂå¾ÇÁ{§É·ÓÅ@¤Î²Îp¤ÀªR¬ã¨sªÀ¸s | ªø©°§Þ³N¾Ç°| | ¨ä¥L¡G®v±Ð¾Ç¼W¯àªÀ¸s¥l¶°¤H | 2010/08/01 | 2011/01/31 | |
099 | °ê¥ß¤¤¥¿¤j¾Ç ¥Í©R¬ì¾Ç¨tº[¤À¥Í©Ò¡B¥ÍÂå©Ò | ¨ä¥L¡G»Y®ÕºtÁ¿: ¦A¥ÍÂå¾Ç¤§À³¥Î | 2010/10/08 | ||||
099 | °ê¥ß»OÆW®ü¬v¤j¾Ç¥Í©R¬ì¾Ç°|¹«~¬ì¾Ç¨t | ¨ä¥L¡G±MÃDºtÁ¿ | 2011/03/31 | ||||
100 | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç | ¨ä¥L¡G±Ð®v±Ð¾Ç¼W¯àªÀ¸s¥l¶°¤H | 2012/02/13 | ||||
101 | ªø©°ÂåÀø°]¹Îªk¤H¹Å¸qªø©°¬ö©ÀÂå°|°ü²£¬ì | ¨ä¥L¡G·F²ÓM©ó°ü²£¬ìªº¬ã¨s | 2012/08/17 | ||||
101 | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç | ¨ä¥L¡G·P¬VÂå¾Ç¥Íª«¼Ð»x»PÁ{§É·ÓÅ@¬ã¨sªÀ¸s¥l¶°¤H | 2012/09/01 | ||||
101 | BMC CANCER | ¨ä¥L¡GReviewer ½×¤å¼f¬d | 2012/09/19 | ||||
101 | ªø©°ÂåÀø°]¹Îªk¤Hªø©°¬ö©ÀÂå°|°ª¶¯°|°Ïª½¨z¬ì | ¨ä¥L¡G¥H³J¥Õ½èÅé¤èªk±´¯ÁÍÁତƦX¤Æ¦Xª«§Ü¤j¸zª¢¤§¬¡©Ê¬ã¨s | 2012/10/05 | ||||
101 | Pharmaceutical Biology | ¨ä¥L¡GReviewer ½×¤å¼f¬d | 2012/10/17 | ||||
101 | ªø©°ÂåÀø°]¹Îªk¤H°ª¶¯ªø©°¬ö©ÀÂå°|¥~¬ì³¡ | ¨ä¥L¡G¸ó»â°ì¾ã¦X«¬¬ã¨s¤èªk¤§²{ªp»P¥¼¨ÓÁÍ¶Õ | 2012/11/14 | ||||
101 | ¦æ¬F°|°êx°h°£§Ð©x§L»²¾É©eû·|»O¤¤ºa¥ÁÁ`Âå°| | ¨ä¥L¡G¤À¤lÂå¾ÇÀËÅ礧¾ã¦X©Ê¬ã¨s¤èªk | 2012/11/28 | ||||
101 | ®Õ¤º | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç | ¨ä¥L¡G·P¬VÂå¾Ç¥Íª«¼Ð»x»PÁ{§É·ÓÅ@¬ã¨s¸s¥l¶°¤H | 2013/03/01 | |||
101 | ®Õ¥~ | ¸²µå¤ý¥Í§ÞªÑ¥÷¦³¤½¥q | ¨ä¥L¡GµUÀYÛ£µo»Ãµßµ·Å餧µÑ¨úª«©µ½w°I¦Ñ¥\¯àµû¦ô¸ÕÅç | 2013/03/06 | |||
101 | ®Õ¥~ | Food and Chemical Toxicology | ¨ä¥L¡GReviewer ½×¤å¼f¬d | 2013/03/20 | |||
101 | ®Õ¥~ | Journal of Physiology and Pharmacology | ¨ä¥L¡GReviewer ½×¤å¼f¬d | 2013/05/07 | |||
101 | ®Õ¥~ | ¤¤µØ¥Íª«¸ê·½À³¥Î¨ó·| | ¨ä¥L¡Gµoªí¡uµUÀYÛ£¬ÛÃö¬ã¨s¡vºt»¡ | 2013/05/26 | |||
101 | ®Õ¥~ | ¦æ¬F°|°êx°h°£§Ð©x§L»²¾É©eû·|¥x¤¤ºa¥ÁÁ`Âå°| | ¨ä¥L¡G¤ÑµMÃĪ«§Ü¤j¸zÀùªº¾÷Âà | 2013/06/19 | |||
102 | ®Õ¤º | °]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ¹Å¸q¤À³¡Å@²z¨t | ¨ä¥L¡G¾á¥ô¹Å¸q¤À³¡Å@²z¨t±Ð®v¾Ç³Nº[¬ã¨sµo®i²Õ²Õªø | 2013/08/01 | |||
102 | ®Õ¥~ | °]¹Îªk¤H¥xÆW¤À¤lÂå¾Ç·| | ¨ä¥L¡G¾á¥ô²Ä¤T©¡²Ä¤G¦¸·|û¤j·|º[¾Ç³N¬ã°Q·|ºtÁ¿ªÌ | 2013/09/15 | |||
102 | ®Õ¥~ | °ê¥ß¹Å¸q¤j¾Ç | ¨ä¥L¡G±MÃDºtÁ¿_ÃĥίuµßµUÀYÛ£¶}µo¦b¹«~°·±d¤äÀ³¥Î | 2013/10/07 | |||
102 | ®Õ¥~ | World Journal of Gastroenterology | ¨ä¥L¡G¾á¥ô°ê»Ú´Á¥Z½s¼fªA°È | 2013/10/20 | |||
102 | ®Õ¥~ | World Journal of Gastroenterology | ¨ä¥L¡G¾á¥ô°ê»Ú´Á¥Z½s¼fªA°È | 2013/11/18 | |||
102 | ®Õ¤º | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç¥Á¥Í¾Ç°| | ¨ä¥L¡G¾á¥ô¥Á¥Í¾Ç°|¥Á¥Í²£·~¬ãµo¤¤¤ßÅU°Ý | 2014/02/01 | |||
102 | ®Õ¥~ | ¤¤µØ¤t±T¯gÃöÃh¨ó·| | ¨ä¥L¡G¾á¥ô¨ó·|²Ä¤@©¡ ²z¨Æ | 2014/02/15 | |||
102 | ®Õ¥~ | Tumor Biology | ¨ä¥L¡GReviewer ½×¤å¼f¬d | 2014/03/06 | |||
102 | ®Õ¥~ | Integrative Cancer Therapies | ¨ä¥L¡GReviewer ½×¤å¼f¬d | 2014/03/14 | |||
102 | ®Õ¥~ | ¹Å¸q¿¤¤»¸}¶m§ó¼d°ê¥Á¤p¾Ç | ¨ä¥L¡G¾á¥ôÁ¿®y | 2014/04/23 | |||
102 | ®Õ¥~ | °ê¥ß¹Å¸q¤j¾Ç¥Í¤Æ¬ì§Þ¾Ç¨t | ¨ä¥L¡G¬ã¨s©ÒºÓ¤h¥Í³¢Âí¹ü½×¤å«ü¾É±Ð±Â | 2014/07/16 | |||
102 | ®Õ¥~ | °ê¥ß¹Å¸q¤j¾Ç¥Í¤Æ¬ì§Þ¾Ç¨t | ¨ä¥L¡G¥Í¤Æ¬ì§Þ¾Ç¨t¬ã¨s©ÒºÓ¤h¥Í±i³ÍÓ}½×¤å«ü¾É±Ð±Â | 2014/07/16 | |||
103 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç | ¨ä¥L¡G¾á¥ô¹Å¸q¤À³¡¶i׳¡¤G¦~¨î¤@¦~¥|¯Z¾É®v | 2014/09/01 | |||
103 | ®Õ¥~ | ¹Å¸qªø©°¬ö©ÀÂå°| ¾ã§Î¥~¬ì | ¨ä¥L¡G¾á¥ôÁ¿®y | 2014/09/23 | |||
103 | ®Õ¥~ | °ê¥ß¤¤¥¿¤j¾Ç¥Í¥Í©R¬ì¾Ç¨t | ¨ä¥L¡G±MÃDºtÁ¿ | 2014/10/17 | |||
103 | ®Õ¥~ | °ª¶¯¥«¥ß¤¤¤s°ª¯Å¤¤¾Ç | ¨ä¥L¡G¶i¦æ±MÃDºtÁ¿ | 2014/10/25 | |||
103 | ®Õ¥~ | ¥xÆW¤À¤lÂå¾Ç·| | ¨ä¥L¡G¾á¥ô2014¦~·|û¤j·|º[¾Ç³N¬ã°Q·|Á¿ªÌ | 2014/11/09 | |||
103 | ®Õ¥~ | À¹¼w´ËÂåÀø°]¹Îªk¤H¹Å¸q°ò·þ±ÐÂå°| | ¨ä¥L¡G¬ã¨spµe¼f¬dªA°È | 2015/05/31 | |||
104 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç | ¨ä¥L¡G¾á¥ô¹Å¸q¤À³¡²£¾Ç¦X§@µo®iº[°ê»Ú¥æ¬y©eû·|¥D©e | 2015/08/01 | |||
104 | ®Õ¥~ | Journal of Cellular and Molecular Medicine. | ¨ä¥L¡GReviewer ½×¤å¼f¬d | 2015/08/04 | |||
104 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß | ¨ä¥L¡G¾á¥ô±Ð¨ôpµe¡uªø©°®v¥Ítalk show¡v-¡u¦æ¨ì¤ô½a³B¡B§¤¬Ý¶³°_®É¡G§Úªº¾Ç«ä¾úµ{¡vÁ¿®v | 2015/10/06 | |||
104 | ®Õ¥~ | ¹A·~¥Í§Þ¤ÀªR»P«P¶i¿ì¤½«Ç | ¨ä¥L¡G¾á¥ô¬ì§Þ³¡·s¹A·~¥Í§Þ²£¾Ç´C¦X·|Âå¹A¸ó»â°ì¨t¦C¡G°·±d¹«~²£·~Á¿ªÌ | 2016/07/25 | |||
105 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç | ¨ä¥L¡GÝ¥ô¹Å¸q¤À³¡Å@²z¨t²£¾Ç¦X§@µo®iº[°ê»Ú¥æ¬y©eû·| | 2016/08/01 | |||
105 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç¬ã¨sµo®i³B | ¨ä¥L¡G¹êÅç°Êª«·ÓÅ@¤Î¨Ï¥Î¤p²Õ©eû | 2016/11/01 | |||
105 | ®Õ¥~ | °¨°ºÂåÅ@ºÞ²z±M¬ì¾Ç®Õ | ¨ä¥L¡G¡u²£¾Ç¬ã²ß¡vÁ¿®v | 2016/12/13 | |||
105 | ®Õ¥~ | ¤¤µØ¥Íª«¸ê·½À³¥Î¨ó·| | ¨ä¥L¡G©ó¡u²Ä¤©¡§Þ³N³Ð§@¤j½à¡vµoªíºt»¡ | 2017/06/11 | |||
106 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç | ¨ä¥L¡G¾á¥ô106-107¾Ç¦~«×¹Å¸q¤À³¡Å@²z¨t±Ð®vµû¼f©eû·| | 2017/08/01 | |||
106 | ®Õ¤º | ªø©°¬ì§Þ¤j¾ÇºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß | ¨ä¥L¡G¨ó§UŪ®Ñ·|¤u§@ | 2017/08/01 | |||
106 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß | ¨ä¥L¡G¾á¥ô¾Ç«ä¾úµ{¸gÅç¤À¨É·|Á¿ªÌ | 2017/11/21 | |||
106 | ®Õ¤º | ªø©°¬ì§Þ¤j¾ÇºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß | ¨ä¥L¡G¨ó§UŪ®Ñ·|¤u§@ | 2018/02/01 | |||
106 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß | ¨ä¥L¡Gt³d107¾Ç¦~«×±Ð¨|³¡°ª±Ð²`¯Ñpµe1-1-A«p´Ó¾Ç¥Í°ò¦¯à¤O¡A¨Ã¾á¥ôpµe¥D«ù¤H¡C | 2018/02/01 | |||
106 | ®Õ¥~ | ¬ì§Þ³¡ | ¾á¥ô¬F©²¾÷ºc±M·~©eû·|©eû | 2018/02/01 | |||
107 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¨ä¥L¡G¾á¥ô107¾Ç¦~«×¹Å¸q¤À³¡Å@²z¨t±Ð®vµû¼f©eû·|©eû | 2018/08/01 | |||
107 | ®Õ¤º | ªø©°¬ì§Þ¤j¾ÇºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß | ¨ä¥L¡G¨ó§U¡uŪ®Ñ·|¡v¤u§@ | 2018/08/01 | |||
107 | ®Õ¤º | ªø©°¬ì§Þ¤j¾ÇÀô¹Ò¦w¥þ½Ã¥Í«Ç | ¨ä¥L¡G¾á¥ô¥Íª«¦w¥þ·|©eû | 2018/08/01 | |||
107 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç | ¨ä¥L¡G¾á¥ô¹êÅç°Êª«·ÓÅ@©eû¤Î¨Ï¥Î¤p²Õ©eû | 2018/08/01 | |||
107 | ®Õ¥~ | ¤¤¤sÂå¾Ç¤j¾Ç | ¨ä¥L¡G¾á¥ôÂå¾ÇÀ³¥Î¤Æ¾Ç¨tºÓ¤h¯Z¬ã¨s¥Í½×¤å¤f¸Õ¤§¦Ò¸Õ©eû | 2019/01/22 | |||
107 | ®Õ¥~ | ¬ì§Þ³¡ | ¾á¥ô¬F©²¾÷ºc±M·~©eû·|©eû | 2019/02/01 | |||
107 | ®Õ¤º | ªø©°¤j¾Ç | ¨ä¥L¡G¾á¥ôªø©°¤j¾Ç107¾Ç¦~«×²Ä¤G¾Ç´Á³Õ¤h¯Z¬ã¨s¥Í¾Ç¦ì¦Ò¸Õ¦Ò¸Õ©eû | 2019/06/27 | |||
107 | ®Õ¥~ | °ê¥ß°ª¶¯¬ì§Þ¤j¾Ç | ¨ä¥L¡G¾á¥ô107¾Ç¦~«×²Ä2¾Ç´ÁºÓ¤h¯Z¬ã¨s¥Í¾Ç¦ì¦Ò¸Õ©eû | 2019/07/31 | |||
108 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç | ¨ä¥L¡G108¡B109¾Ç¦~«×¾û¥Ó¶Dµûij©eû·|©eû | 2019/08/01 | |||
108 | ®Õ¤º | ªø©°¬ì§Þ¤j¾ÇºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß | ¨ä¥L¡G¨ó§U¡uŪ®Ñ·|¡v¤u§@ | 2019/08/01 | |||
108 | ®Õ¤º | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡ | ¨ä¥L¡G¾á¥ô¾Ç¥ÍªÀ¹Î¡u¼²²yªÀ¡v«ü¾É¦Ñ®v | 2019/08/01 | |||
108 | ®Õ¥~ | °ª¶¯¥«¤¤¤s°ª¯Å¤¤¾Ç | ¨ä¥L¡G±MÃDºtÁ¿ | 2019/09/24 | |||
108 | ®Õ¥~ | ¤¤¤sÂå¾Ç¤j¾Ç | ¨ä¥L¡G¾á¥ô108¾Ç¦~«×¸ó»â°ì¾Çµ{³Ð·s³Ð·N³Ð·~¤u§@§{ | 2019/10/30 |
¾Ç³N¬¡°Ê¦Cªí
|
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I ) |
¦~«× | ¬¡°Ê¦WºÙ/¶i×½Òµ{ | ¥D¿ì³æ¦ì/¶i×¾÷ºc | ¬¡°ÊºØÃþ | ¬¡°Ê«¬ºA | ¬¡°Ê¦aÂI | °Ñ»P±¡§Î | ¶}©l¤é´Á | µ²§ô/§¹¦¨¤é´Á | ®É¼Æ |
097 | ¤þºØ³Ò¤u¦w¥þ½Ã¥Í·~°È¥DºÞ¦w¥þ½Ã¥Í±Ð¨|°V½m | ¥xÆW¬Ù¦w¥þ½Ã¥Í±Ð¨|¨ó·| | ¶i׬ã²ß | °ê¤º | °Ñ¥[ | 2008/11/10 | 2008/11/17 | 12 | |
097 | 2008»O¤é³J¥Õ½èÅé¾Ç¬ã°Q·| | »OÆW³J¥ÕÅé¾Ç·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | °ê¤º | °Ñ¥[ | 2008/12/03 | 2008/12/05 | 12 |
097 | ²Ä24©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | °ê¤º | °Ñ¥[ | 2009/03/21 | 2009/03/22 | 8 |
097 | §K¬Ì¯e¯f·ÓÅ@¬ã²ß·| | ªø©°§Þ³N¾Ç°|¹Å¸q¤À³¡ | ¶i׬ã²ß | °ê¤º | ¥D¿ì | 2009/06/11 | 2009/06/12 | 16 | |
098 | ¹êÃÒÅ@²z¾Ç:¶q¤Æ¬ã¨s(Evidence-based Nursing: A Quantitative Perspective) | ªø©°§Þ³N¾Ç°|¹Å¸q¤À³¡ | ¶i׬ã²ß | °ê¤º | ¥D¿ì | 2009/11/13 | 2009/11/13 | 8 | |
098 | ¥tÃþÀøªkªºÃÀ³N¡X¹B¥ÎªÚ»Àøªk©óºC©Ê·ÓÅ@ | ¹Å¸q¤À³¡Å@²z¨t | ¶i׬ã²ß | °ê¤º | ¥D¿ì | 2010/04/01 | 2010/04/02 | 12 | |
099 | °ê»Úªø´Á·ÓÅ@¾÷ºc¸gÀç:ºÞ²z «OÀI»P¸ê·½¹B¥Î | ªø©°§Þ³N¾Ç°| | ¬ã²ß | °ê¤º | ¥D¿ì | 2010/10/21 | 2010/10/22 | 16 | |
099 | ÂàĶÂå¾Ç¬ã°Q·|º[¥xÆW³J¥Õ½èÅé¾Ç·|¦~·| | °ê¥ß¶§©ú¤j¾Ç | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | °ê¤º | °Ñ¥[ | 2011/04/27 | 2011/04/28 | 16 |
099 | ±Ð®v&¾Ç¥Í¤§ªÀ¸s¹ï¸Ü¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç±M®×¿ì¤½«Ç | ¬ã²ß | °ê¤º | °Ñ¥[ | 2011/06/09 | 2011/06/09 | 8 | |
100 | ¤¤ÂåÅ@²z¹êÃÒÁÍ¶Õ | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì»Ú¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ½Ð¿ï¾Ü | ¥xÆW¡A¤¤µØ¥Á°ê | ¥D¿ì | 2011/10/27 | 2011/10/28 | 16 |
100 | °·±d«O¨x±Ð®v¬ã¨sªÀ¸s | §d»ñ¬ì§Þ¤j¾Ç | ¾Ç³N¬ã°Q·| | ¨ä¥L§Î¦¡ | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2012/01/04 | 2012/01/04 | 3 |
100 | ²Ä27©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2012/03/17 | 2012/03/18 | 16 |
100 | ±Ð®v±Ð¾Ç¼W¯àªÀ¸s¦¨ªGµoªí·| | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2012/06/29 | 2012/06/29 | 7 | |
101 | ¤HÅé¸ÕÅç¬ã¨s¤HûÁ¿²ß¯Z°Ñ¥[ÃÒ©ú | ªø©°ÂåÀø°]¹Îªk¤H¤HÅé¸ÕÅçÛ²z©eû·| | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2012/08/18 | 2012/08/18 | 8 | |
101 | ¯e¯f¤§µoª¢¤ÏÀ³»PÁ{§É·ÓÅ@¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | ¥D¿ì | 2012/10/25 | 2012/10/26 | 16 | |
101 | The Experiences Of Tobacco Use Among Adolescent Boys After Smoking-Cessation Programs | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/01/22 | 2013/01/22 | 1 | |
101 | ¤÷¥À¿ËªÀ¸g¦a¦ì»P°ê¤¤¥ÍªÎD¤§±´°Q¡G¥H2011¦~¥xÆWÀç¾i°·±d½Õ¬d¸ê®Æ¬°¨Ò | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/02/27 | 2013/02/27 | 1 | |
101 | ²Ä28©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/03/23 | 2013/03/24 | 16 |
101 | ¸ê¦wÁ¿²ß½Òµ{¦w¥þ¤Wºô¾Þ§@¤Î¨¾½d¹q¤l¶l¥óªÀ¥æ¤uµ{¦w¥þ«Å¾É | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ¹Å¸q¤À³¡¹qºâ¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/03/28 | 2013/03/28 | 3 | |
101 | °·±d»P¥Í¬¡«~½è¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/04/18 | 2013/04/19 | 16 | |
101 | International Bone and Mineral Society and The Japanese Society for Bone and Mineral Research | The International Bone and Mineral Society | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¤é¥» | °Ñ¥[ | 2013/05/28 | 2013/06/01 | 40 |
101 | ¾³õ¹ê²ß©ÊÄÌÂZ¤§¨¾ªv»P³B¸m¬ã°Q·| | ªø©°¬ì§Þ¤j¾Ç©Ê§O¥µ¥±Ð¨|©eû·| | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/06/05 | 2013/06/05 | 2.5 | |
101 | ¥ÀÀ¦·ÓÅ@ªº±À¤â-¥H¤fz¾ú¥v¬ã¨sªk±´¨s¾Ô«áªº²£±C¥Í²P(1921-1989) | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/06/20 | 2013/06/20 | 1 | |
102 | Pulmonary rehabilitation research in Taiwan¡GPast, Present, & Future Challenge | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/08/21 | 2013/08/21 | 1 | |
102 | ¯S±Ðª¾¯à¬ã°Q·|ij-¡mADHD¾Ç¥Íªºµo±¸»P¤¶¤J¡n | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ¾Ç°È³B¿Ô°Ó¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/09/04 | 2013/09/04 | 3 | |
102 | ÃöÃh¾Ç¥Í±¡ºü¾AÀ³»P¦Û¶Ë¦æ¬°ªº¹w¨¾»²¾É | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡ ¾Ç°È²Õ | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/09/04 | 2013/09/04 | 2 | |
102 | °·±d¸ê®Æ®w©óÁ{§ÉÀ³¥Î¬ã²ß·| | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/10/24 | 2013/10/25 | 16 | |
102 | ¦h¤¸¾Ç²ßµû¶q¦¨ªGµoªí·| | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç±Ð°È³B | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/10/31 | 2013/10/31 | 4 | |
102 | ¦h¤¸¾Ç²ßµû¶q±M®a®y½Í·| | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ±Ð°È³B | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/10/31 | 2013/10/31 | 4.5 | |
102 | 102 ¦~«×¡u·L§K¤ÎÀËÅçÂå¾Ç¡vº[¡u¥Í¤Æ¤ÎÃIJzÂå¾Ç¡v¸ó¾Çªù¾Ç³N¥æ¬y¬ã°Q·| | ¦æ¬F°|°ê®a¬ì¾Ç©eû·| | ¾Ç³N¬ã°Q·| | ¨ä¥L§Î¦¡ | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2013/11/02 | 2013/11/02 | 7 |
102 | ²Ä29©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2014/03/15 | 2014/03/16 | 16 |
102 | ¤HÅé¸ÕÅç¬ã¨s¤HûÁ¿²ß¯Z | ªø©°ÂåÀø°]¹Îªk¤H¹Å¸qªø©°¬ö©ÀÂå°| | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2014/05/10 | 2014/05/10 | 4 | |
102 | 2014²Ä¤G©¡§Þ³N³Ð§@¤j½à | ¤¤µØ¥Íª«¸ê·½À³¥Î¨ó·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2014/05/25 | 2014/05/25 | 5 |
102 | ICBPS 2014: International Conference on Biomedicine and Pharmaceutical Sciences | World Academy of Science , Engineering And Technology (WASET) | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¤é¥» | °Ñ¥[ | 2014/05/29 | 2014/05/30 | 16 |
103 | ©I§l·ÓÅ@¨t~¹êÃÒÂå¾Ç¤§¾Ç²ß»P«ü¾É¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡©I§l·ÓÅ@¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2014/10/18 | 2014/10/18 | 8 | |
103 | ¤¤¯óÃÄ»PÃĥίuµß¶}µo¦bÁ{§ÉÂåÅ@À³¥Î¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | ¥D¿ì | 2014/10/23 | 2014/10/24 | 16 | |
103 | ²Ä¤G¤Q¤T©¡²ÓM¤Î¤À¤l¥Íª«·sª¾¬ã°Q·| | ¤¤µØ¥Á°ê²ÓM¤Î¤À¤l¥Íª«¾Ç¾Ç·|¡B°]¹Îªk¤H°ê®a½Ã¥Í¬ã¨s°| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2015/02/04 | 2015/02/06 | 24 |
103 | ²Ä30©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2015/03/21 | 2015/03/22 | 16 |
103 | ¤HÅé¸ÕÅç»P¨ü¸ÕªÌ«OÅ@Û²z¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | ¥D¿ì | 2015/04/24 | 2015/04/24 | 9 | |
103 | 2015 International Congress on Chemical, Biological and Environmental Sciences | Higher Education Forum | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¤é¥» | °Ñ¥[ | 2015/05/07 | 2015/05/09 | 24 |
103 | ¼Æ¦ì±Ð¾Ç±M®a®y½Í·| | ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2015/06/11 | 2015/06/11 | 4 | |
104 | °·«O¸ê®Æ®wÀ³¥Î»P®i±æ | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¨ä¥L§Î¦¡ | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2015/10/23 | 2015/10/23 | 2 |
104 | °ê»ÚÂåÀø¤ÎªÀ°Ï°·±d«P¶i¤À¨É | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¨ä¥L§Î¦¡ | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2015/10/23 | 2015/10/23 | 2 |
104 | ²Ä31©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2016/03/26 | 2016/03/27 | 16 |
104 | ¯f¤H¦w¥þ²z½×»P¹ê°ÈÀ³¥Î¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | ¥D¿ì | 2016/04/21 | 2016/04/22 | 16 | |
104 | ¸ê¦wÁ¿²ß½Òµ{-2016Ó¸ê¥~¬ª¹ê°È®×¨Ò¨¾Å@½g | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡¹Ï¸ê²Õ | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2016/04/29 | 2016/04/29 | 3 | |
104 | ¤p¦Ó¬ü¡G·L¾Ç¤À»P·L«¬½Òµ{ | ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2016/05/23 | 2016/05/23 | 4.5 | |
104 | ªø´Á·ÓÅ@ªA°È²{ªp»Pµo®i¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç©I§l·ÓÅ@¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2016/06/03 | 2016/06/03 | 8 | |
104 | The 39th Annual Meeting of the Japan Neuroscience Society | The Japan Neuroscience Society (JNS) | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¤é¥» | °Ñ¥[ | 2016/07/20 | 2016/07/22 | 24 |
105 | ²Ä¤T¤Q¤G©¡¥Íª«®L¥OÀç | °ê¥ß¦¨¥\¤j¾ÇÂå¾Ç°|¡B¬ì§Þ³¡¥Í©R¬ì¾Ç¬ã¨s±À°Ê¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2016/08/04 | 2016/08/06 | 24 | |
105 | ¼Æ¦ì±Ð»P¾Ç©óÅ@²z¤§À³¥Î¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | ¥D¿ì | 2016/10/20 | 2016/10/21 | 16 | |
105 | ¾Ç³NÛ²z¬ã²ß | ªø©°¬ì§Þ¤j¾Ç¬ã¨sµo®i³B | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/02/24 | 2017/02/24 | 3 | |
105 | ²Ä32©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/03/25 | 2017/03/26 | 16 |
105 | ©Ê§O¥µ¥»P°·±d·ÓÅ@¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/04/27 | 2017/04/28 | 16 | |
105 | ¬ã¨sÛ²z¬ã¨s·|(§t§Q¯q½Ä¬ðºÞ²z) | ªø©°¬ì§Þ¤j¾Ç | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/05/12 | 2017/05/12 | 4 | |
105 | ®Õ¶é¾Ç³NÛ²z | ªø©°¬ì§Þ¤j¾Ç | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/05/19 | 2017/05/19 | 3 | |
105 | 1-3-BÅ@²z¼Æ¦ì±Ð§÷À³¥Î¤u§@§{ | ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/06/28 | 2017/06/28 | 2 | |
105 | The 40th Annual Meeting of the Japan Neuroscience Society. | The Japan Neuroscience Society (JNS) | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¤é¥» | °Ñ¥[ | 2017/07/20 | 2017/07/23 | 24 |
106 | ²Ä33©¡¥Íª«®L¥OÀç | °ê¥ß¤¤¿³¤j¾Ç | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/08/23 | 2017/08/25 | 24 | |
106 | 106¦~«×IACUC©eû·|©Î¤p²Õ°ò¦°V½m¯Z | °]¹Îªk¤H¹A·~¬ì§Þ¬ã¨s°| | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/08/29 | 2017/08/30 | 12 | |
106 | PBL±Ð¾Çºë¶i¤u§@§{ | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/09/13 | 2017/09/13 | 8 | |
106 | Å@²z¤Hûªk«ß»P³Ò°ÊÅv¯q¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/10/26 | 2017/10/27 | 16 | |
106 | 3RÆ[ÂI½Í°Êª«¹êÅç·ÓÅ@ | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç¬ã¨sµo®i³B | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/11/03 | 2017/11/03 | 2 | |
106 | 2017¥Í¤Æ¬î¥OÀç | ¥xÆW¥Íª«¤Æ¾Ç¤Î¤À¤l¥Íª«¾Ç¾Ç·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2017/11/17 | 2017/11/19 | 16 |
106 | 106¾Ç¦~«×®v¥Í¹ê°È¼W¯à¸ó®Õ²`«×¹ê°È¬ã²ßpµe-¤ßªÍ¾i¥Í«O°·»Pªø´Á·ÓÅ@À³¥Î¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç©I§l·ÓÅ@¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2018/03/08 | 2018/04/27 | 112 | |
106 | ²Ä33©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ²Ä33©¡¥Íª«Âå¾ÇÁp¦X¦~·|Äw³Æ©eû·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2018/03/24 | 2018/03/25 | 16 |
106 | ¾É®v»²¾Éª¾¯à¬ã²ß-¤j±M¥Í¨¤ß¾AÀ³»P»²¾Éµ¦²¤ | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡¾Ç°È²Õ | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2018/04/13 | 2018/04/13 | 2 | |
106 | ¸ó»â°ì¹êÃÒ¹ê°È¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2018/04/26 | 2018/04/27 | 16 | |
106 | ¾·~¦w¥þ½Ã¥Í¦b¾±Ð¨|°V½m | ªø©°¬ì§Þ¤j¾ÇÀô¹Ò¦w¥þ½Ã¥Í«Ç | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2018/05/11 | 2018/05/11 | 3 | |
106 | ªÅ®ð«~½è¨¾Å@¤u§@§{ | ªø©°¬ì§Þ¤j¾ÇºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2018/05/17 | 2018/05/17 | 8 | |
106 | ¤HÅé¸ÕÅç¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2018/05/23 | 2018/05/23 | 4 | |
106 | 2018°ê»Ú¥Íª«Âå¾Ç¬ã°Q·|&²Ä15©¡«e¤¥Íª«Âå¾Ç·sª¾¬ã°Q·| | ¤¤°êÂåÃĤj¾Ç | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2018/06/29 | 2018/06/30 | 16 |
106 | The 41st Annual Meeting of the Japan Neuroscience Society | The Japan Neuroscience Society | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¤é¥» | °Ñ¥[ | 2018/07/26 | 2018/07/29 | 32 |
107 | ¦h¤¸¤å¤Æ±Ð¾Ç»PÂåÅ@°ê»Ú²¾°Ê§Q¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2018/10/25 | 2018/10/26 | 16 | |
107 | 2018¥Í¤Æ¬î¥OÀç | ¥xÆW¥Íª«¤Æ¾Ç¤Î¤À¤l¥Íª«¾Ç¾Ç·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | ¥D¿ì | 2018/11/09 | 2018/11/11 | 24 |
107 | ²Ä26©¡²ÓM¤Î¤À¤l¥Íª«·sª¾¬ã°Q·| | ¤¤µØ¥Á°ê²ÓM¤Î¤À¤l¥Íª«¾Ç¾Ç·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2019/01/23 | 2019/01/25 | 16 |
107 | «OÅ@´¼¼z°]²£Åv | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡¹Ï¸ê²Õ | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2019/03/08 | 2019/03/08 | 1 | |
107 | 2019¦~·|û¤j·|º[¾÷¯à©Ê¹«~§ïµ½¥NÁ²§±`»P¦Ñ¤Æ¤§°ê»Ú¬ã°Q·| | ¥xÆW«O°·¹«~¾Ç·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2019/03/15 | 2019/03/15 | 8 |
107 | ²Ä34©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ²Ä34©¡¥Íª«Âå¾ÇÁp¦X¦~·| | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2019/03/23 | 2019/03/24 | 16 |
107 | ±Ð¾Ç³]p»P¦h¤¸µû¶q¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2019/04/25 | 2019/04/26 | 14 | |
107 | 107¾Ç¦~«×®ü¥~²`«×¹ê°È¬ã²ß¦¨ªG¤À¨É | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2019/05/15 | 2019/05/15 | 2 | |
107 | ¤HÅé¬ã¨sº[¨ü¸ÕªÌ«OÅ@½Òµ{¬ã²ß·| | ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2019/06/21 | 2019/06/21 | 4 | |
107 | The 42nd Annual Meeting of the Japan Neuroscience Society | The Japan Neuroscience Society (JNS) | ¾Ç³N¬ã°Q·| | ¤½¶}¼x½Z | ¤é¥» | °Ñ¥[ | 2019/07/25 | 2019/07/28 | 32 |
108 | ²Ä35©¡¥Íª«®L¥OÀç | ¬ì§Þ³¡¥Í©R¬ì¾Ç¬ã¨s±À°Ê¤¤¤ß | ¬ã²ß | ¨ä¥L§Î¦¡ | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2019/08/25 | 2019/08/27 | 24 |
108 | ¥þ^¤å½Òµ{³]p»P±Ð¾Ç¬ã²ß·| | ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t | ¬ã²ß | ¥xÆW¡A¤¤µØ¥Á°ê | °Ñ¥[ | 2019/10/25 | 2019/10/25 | 7 |
©Ó±µpµe®×¦Cªí
|
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I ) |
¦~«× | ®×¦W | Ãþ«¬ | °_©l¤é´Á | µ²§ô¤é´Á | ¤u§@Ãþ§O |
098 | ¥H³J¥Õ½èÅé¤èªk±´¯Á´Óª«©Ê²üº¸»X¥H¤£¦PAÀôßm°ò¨ú¥N¤§Ãþ¶ÀତƦXª«§Ü¤HÅé¤j¸zÀù²ÓM¤§¬¡©Ê¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2009/11/02 | 2011/10/31 | ¥D«ù¤H |
098 | ¤£¦P¨Ó·½ªº¤HÃþ¶¡½è·F²ÓM¤§¥\¯à©Ê³J¥Õ½èªí²{¬ã¨s¡G transgelin-2¦b¶¡½è·F²ÓM¤À¤Æ½Õ±±¤§¬ã¨s | ®Õ¤º¸É§U®×(K) | 2010/03/01 | 2011/02/28 | ¥D«ù¤H |
098 | Transgelin³J¥Õ¦b¤j¸zµ²¸zÀù²ÓMªºªí²{»P±´°Q©Ò§êºt¤§¨¤¦â1/2 | ¥ø·~²£¾Çpµe(F) | 2010/06/01 | 2012/05/31 | ¦@¦P¥D«ù¤H |
099 | ¥H´Óª«©Ê²üº¸»X¤§Ãþ¶ÀତƦXª«§í¨î¤HÃþ¯×ªÕ²ÓM¤À¤Æ¤§¬ã¨s(1/2) | ¥ø·~²£¾Çpµe(F) | 2010/09/01 | 2011/08/31 | ¦@¦P¥D«ù¤H |
099 | ¤£¦P¤fµÄÀô¹Ò¹ï©ó²Óµß·P¬V³y¦¨¤HÃþ¾¦ÅiÅÖºû¥À²ÓMµoª¢¤§¤À¤l¾÷¨î»PÃþ¶ÀତƦXª«§Üµoª¢¤§¬ã¨s(1/2) | ¥ø·~²£¾Çpµe(F) | 2010/09/01 | 2011/08/31 | ¦@¦P¥D«ù¤H |
099 | ¥H³J¥Õ½èÅé¤èªk±´¯Á´Óª«©Ê²üº¸»X¥H¤£¦PAÀôßm°ò¨ú¥N¤§Ãþ¶ÀତƦXª«§Ü¤HÅé¤j¸zÀù²ÓM¤§¬¡©Ê¬ã¨s(2/2) | ®Õ¤º¸É§U®×(K) | 2010/11/01 | 2011/10/31 | ¥D«ù¤H |
099 | ·s¿oÀù¯g¥Íª««ü¼Ð¡G Transgelin ³J¥Õ¦b EGF ½Õ±±°T®§¶Ç»¼路®|³y¦¨ ¤j¸zª½¸zÀù²ÓM«I¥Ç¤§¬ã¨s(1/2) | ¥ø·~²£¾Çpµe(F) | 2011/01/01 | 2011/12/31 | ¦@¦P¥D«ù¤H |
099 | ½Õ¸`©Ê T²ÓM»¤¾É¤j¸zª½¸zÀù²ÓMÁͤƳJ¥Õ SDF-1¤ÎuPA°ò¦]ªí²{¤§¤À¤l¾÷¨î | ¥ø·~²£¾Çpµe(F) | 2011/01/01 | 2011/12/31 | ¦@¦P¥D«ù¤H |
099 | Visfatin¹ï©ó¤HÃþ¤º¥Ö«eÅX²ÓM¥\¯à¤Î°ò¦]ªí²{¤§¼vÅT | ¥ø·~²£¾Çpµe(F) | 2011/01/01 | 2011/12/31 | ¦@¦P¥D«ù¤H |
099 | transgelin-2¦b¤HÃþ°©Å趡½è·F²ÓM¥Íªø¤À¤Æ½Õ±±¤§¬ã¨s | ®Õ¤º¸É§U®×(K) | 2011/03/01 | 2012/02/29 | ¥D«ù¤H |
099 | µUÀYÛ£²£«~©µ½w°I¦Ñ¥\¯àµû¦ô¸ÕÅç | ¥ø·~²£¾Çpµe(F) | 2011/04/01 | 2013/03/31 | ¥D«ù¤H |
099 | Transgelin³J¥Õ¦b¤j¸zµ²¸zÀù²ÓMªºªí²{»P±´°Q©Ò§êºtªº¨¤¦â(2/2) | ¥ø·~²£¾Çpµe(F) | 2011/06/01 | 2012/05/31 | ¦@¦P¥D«ù¤H |
100 | ¤£¦P¤fµÄÀô¹Ò¹ï©ó²Óµß·P¬V³y¦¨¤HÃþ¾¦ÅiÅÖºû¥À²ÓMµoª¢¤§¤À¤l¾÷¨î»PÃþ¶ÀତƦXª«§Üµoª¢¤§¬ã¨s(2/2) | ¥ø·~²£¾Çpµe(F) | 2011/09/01 | 2012/08/31 | ¦@¦P¥D«ù¤H |
100 | ¥H´Óª«©Ê²üº¸»X¤§Ãþ¶ÀତƦXª«§í¨î¤HÃþ¯×ªÕ²ÓM¤À¤Æ¤§¬ã¨s(2/2) | ¥ø·~²£¾Çpµe(F) | 2011/09/01 | 2012/08/31 | ¦@¦P¥D«ù¤H |
100 | ¯×ªÕ¿E¯À»¤¾ÉGÀù²ÓMstromal cell-derived factor-1 (SDF-1)°ò¦]ªí²{¤§¤À¤l¾÷¨î | ¥ø·~²£¾Çpµe(F) | 2011/09/01 | 2012/08/31 | ¦@¦P¥D«ù¤H |
100 | ¤HÃþ°©Å趡ª½·F²ÓM»PÂÀ±a°ò½è·F²ÓM¤§¥\¯à©Ê³J¥Õ½èÅé¬ã¨s:transgelin-2¦b¶¡½è·F²ÓM¥Íªø»P¤À¤Æ½Õ±±¤§¬ã¨s(1/3) | ¥ø·~²£¾Çpµe(F) | 2011/11/01 | 2012/10/31 | ¥D«ù¤H |
100 | ½Õ¸`©ÊT²ÓM»¤¾É¤j¸zª½¸zÀù²ÓMÁͤƳJ¥ÕSDF-1¤ÎuPA°ò¦]ªí²{¤§¤À¤l¾÷¨î(2/2) | ¥ø·~²£¾Çpµe(F) | 2012/01/01 | 2012/12/31 | ¦@¦P¥D«ù¤H |
100 | ·s¿oÀù¯g¥Íª««ü¼Ð¡G Transgelin ³J¥Õ¦b EGF ½Õ±±°T®§¶Ç»¼路®|³y¦¨ ¤j¸zª½¸zÀù²ÓM«I¥Ç¤§¬ã¨s(2/2) | ¥ø·~²£¾Çpµe(F) | 2012/01/01 | 2012/12/31 | ¦@¦P¥D«ù¤H |
101 | ¤HÃþ°©Å趡½è·F²ÓM»PÂÀ±a°ò½è·F²ÓM¤§¥\¯à©Ê³J¥Õ½èÅé¬ã¨s¡Gtransgelin-2¦b¶¡½è·F²ÓM¥Íªø»P¤À¤Æ½Õ±±¤§¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2012/11/01 | 2013/10/31 | ¥D«ù¤H |
101 | ¥H³J¥Õ½èÅé¤èªk¶}µoµUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¤j¹«¯Ê¦å©Ê¸£¤¤·ªº«OÅ@¾÷Âध¬¡©Ê¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2012/11/01 | 2013/10/31 | ¥D«ù¤H |
101 | ¥H³J¥Õ½èÅé¤èªk¶}µoµUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¤j¹«¯Ê¦å©Ê¸£¤¤·ªº«OÅ@¾÷Âध¬¡©Ê¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2012/11/01 | 2013/10/31 | ¥D«ù¤H |
101 | ¥H³J¥Õ½èÅé¤èªk¬ã¨sµUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¤j¹«¯Ê¦å©Ê¸£¤¤·ªº«OÅ@¾÷Âध¬¡©Ê¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2013/01/01 | 2013/12/31 | ¦@¦P¥D«ù¤H |
101 | ±´°Q½Õ¸`©ÊT²ÓM»¤¾Éµoª¢°ò¦]ªí²{³y¦¨¤j¸zª½¸zÀù²ÓM«I¥Ç¾÷¨î¤Wªº¼vÅT | ¥ø·~²£¾Çpµe(F) | 2013/03/01 | 2013/12/31 | ¦@¦P¥D«ù¤H |
101 | ±´°Q°ª¿}Àô¹Ò¤U¤ú©P¯fµß¹ï¤HÃþ¾¦ÅiÅÖºû¥À²ÓM¦b·P¬V¾÷¨î¤Wªº¼vÅT | ®Õ¤º¸É§U®×(K) | 2013/03/31 | 2013/11/30 | ¥D«ù¤H |
101 | ±´°Q°ª¿}Àô¹Ò¤U¤ú¶g¯fµß¹ï¤HÃþ¾¦ÅiÅÖºû¥À²ÓM¦b·P¬V¾÷¨î¤Wªº¼vÅT | ¥ø·~²£¾Çpµe(F) | 2013/04/01 | 2014/03/31 | ¥D«ù¤H |
102 | µUÀYÛ£µßµ·Åéµo»Ã¤§µÑ¨úª«§Ü¤j¸zÀù¬¡©Ê©M¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¾Ç±´¯Á¨ä§Ü¤j¸zÀù¥Íª«¼Ð°O | °ê¬ì·|±MÃD¬ã¨spµe(D1) | 2013/08/01 | 2014/07/31 | ¥D«ù¤H |
102 | ¥H³J¥Õ½èÅé¤èªk±´¯Át-BHP»¤¾É¨xŦ²ÓM·l¶Ë¤§¥Íª««ü¼Ð¤Î¨xª¢³J¥Õªºªí²{¤§¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2013/10/01 | 2014/09/30 | ¦@¦P¥D«ù¤H |
102 | ¤HÃþ°©Å趡½è·F²ÓM»PÂÀ±a°ò½è·F²ÓM¤§¥\¯à©Ê³J¥Õ½èÅé¬ã¨s¡Gtransgelin-2¦b¶¡½è·F²ÓM¥Íªø»P¤À¤Æ½Õ±±¤§¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2013/11/01 | 2014/10/31 | ¥D«ù¤H |
102 | ¥H³J¥Õ½èÅé¤èªk¬ã¨sµUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¤j¹«¯Ê¦å©Ê¸£¤¤·ªº«OÅ@¾÷Âध¬¡©Ê¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2014/01/01 | 2014/12/31 | ¦@¦P¥D«ù¤H |
102 | ±´°Q½Õ¸`©ÊT²ÓM»¤¾Éµoª¢°ò¦]ªí²{³y¦¨¤j¸zª½¸zÀù²ÓM«I¥Ç¾÷¨î¤Wªº¼vÅT(2/3) | ¥ø·~²£¾Çpµe(F) | 2014/03/01 | 2015/02/28 | ¦@¦P¥D«ù¤H |
102 | ±´°Q°ª¿}Àô¹Ò¤U¤ú©P¯fµß¹ï¤HÃþ¾¦ÅiÅÖºû¥À²ÓM¦b·P¬V¾÷¨î¤Wªº¼vÅT(2/2) | ¥ø·~²£¾Çpµe(F) | 2014/04/01 | 2015/03/31 | ¥D«ù¤H |
102 | µUÀYÛ£µßµ·ÅéµÑ¨úª«½Õ¸`¤º½èºôÀ£¤O°T¸¹¹ï¤Úª÷´Ë¤ó¯g°Êª«¯«¸g¤¸Ãa¦º¤Î¦æ¬°¯Ê³´¤§«OÅ@¾÷Âध¬ã¨s | ¬F©²²£¾Çpµe(B) | 2014/06/01 | 2015/05/31 | ¥D«ù¤H |
102 | µUÀYÛ£µßµ·ÅéµÑ¨úª«½Õ¸`¤º½èºôÀ£¤O°T¸¹¹ï¤Úª÷´Ë¤ó¯g°Êª«¯«¸g¤¸Ãa¦º¤Î¦æ¬°¯Ê³´¤§«OÅ@¾÷Âध¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2014/06/01 | 2015/12/31 | ¥D«ù¤H |
103 | ¯×ªc¯Àresistin»¤¾É¤HÃþGÀù²ÓMÂಾ¯à¤OSDF-1°ò¦]ªí²{¤§¾÷Âà¬ã¨s(1/3) | ¥ø·~²£¾Çpµe(F) | 2014/08/01 | 2015/07/31 | ¦@¦P¥D«ù¤H |
103 | µUÀYÛ£µßµ·ÅéµUÀY¯À§í¨î¤j¸zÀù²ÓMÂಾ«Iŧ¤§¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¾Ç±´¯Á¨ä§Ü¤j¸zÀù¤§¼Ð¹v¤À¤l | °ê¬ì·|±MÃD¬ã¨spµe(D1) | 2014/08/01 | 2015/07/31 | ¥D«ù¤H |
103 | µUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¹êÅç©Ê¸£¥~¶Ë°Êª«¯«¸g¤¸Ãa¦º¤§¦A¥Í¾÷Âध¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2014/11/01 | 2015/10/31 | ¥D«ù¤H |
103 | ´Óª«ÆPCIL-102§í¨î¤j¸zÀù¥Íªø©M¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¤èªk±´¯Á¨ä§Ü¤j¸zÀù¤§¼Ð¹v¤À¤l(1/3) | ¥ø·~²£¾Çpµe(F) | 2014/12/01 | 2015/11/30 | ¦@¦P¥D«ù¤H |
103 | ±´°Q°ª¿}»¤¾É¤ú©P¯fµß¹ï¤HÃþ¾¦ÅiÅÖºû¥À²ÓM°ò¦]ªí²{¦b·P¬V¾÷¨î¤Wªº¼vÅT | ¥ø·~²£¾Çpµe(F) | 2015/04/01 | 2016/03/31 | ¥D«ù¤H |
103 | ¡i¾ã¦X«¬p¹º¡j¤t±T¯g§K¬ÌP¯f¾÷Âà¬ã¨s:¤lpµe¤T:¤t±T¯g¦å²M¹ï©ó²O¤Ú²ÓMCD40/BLK/FCGR2A»P¦åºÞ²ÓMµoª¢¤ÏÀ³¤§¼vÅT»P±´°Q©Ò§êºt¤§¨¤¦â | ¥ø·~²£¾Çpµe(F) | 2015/04/01 | 2016/04/30 | ¥D«ù¤H |
104 | ¹B¥Î³J¥Õ½èÅé¾Ç±´°QµUÀYµßµßµ·Åéµo»Ãª«§í¨î¤j¸zÀù¤§¼Ð¹v³J¥Õ¥\¯à»PªíÆ[¿ò¶Ç ½Õ±±ªº¬ÛÃö©Ê¾÷¨î¬ã¨s(1/3) | °ê¬ì·|±MÃD¬ã¨spµe(D1) | 2015/08/01 | 2016/07/31 | ¥D«ù¤H |
104 | §ÜÃĩʤj¸zÀù·F²ÓM®è¤§§ÜÃľ÷¨î¬ã¨s»P¹B¥Î³J¥Õ½èÅé¤èªk±´¯Á¤j¸zÀù·F²ÓM»¤¾Éµoª¢³J¥Õªí²{»P½Õ±±«I¥Ç¾÷¨î¤Wªº¼vÅT | ¥ø·~²£¾Çpµe(F) | 2015/08/01 | 2016/07/31 | ¥D«ù¤H |
104 | À³¥Î¬¡Åé¥ú¾Ç¦¨¹³»P³J¥Õ½èÅé¾Ç§Þ³N±´¯ÁµUÀYÛ£xµ·Åéµo»ÃµÑ¨úª«¹ï©¬ª÷´Ë¤ó¯g°Êª««OÅ@¾÷Âध¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2016/06/01 | 2017/05/31 | ¥D«ù¤H |
105 | ¹B¥Î³J¥Õ½èÅé¾Ç±´°QµUÀYµßµßµ·Åéµo»Ãª«§í¨î¤j¸zÀù¤§¼Ð¹v³J¥Õ¥\¯à»PªíÆ[¿ò¶Ç½Õ±±ªº¬ÛÃö©Ê¾÷¨î¬ã¨s(2/3) | °ê¬ì·|±MÃD¬ã¨spµe(D1) | 2016/08/01 | 2017/07/31 | ¥D«ù¤H |
105 | ±´°Q¤ú©P¯f·P¬V¦åºÞ²ÓM½Õ±±TLR¤Îintegrin°T®§¶Ç»¼³y¦¨°Ê¯ßµw¤Æ¾÷¨î | ¥ø·~²£¾Çpµe(F) | 2016/11/01 | 2017/10/31 | ¥D«ù¤H |
105 | ¹ñ·s¤ÑµMª«µUÀY¯À¢á§í¨î¤HÃþGÀù²ÓMÂಾ«Iŧ¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¤èªk±´¯ÁµUÀY¯À³J¥Õªí²{¤§¬ã¨s(1/3) | ¥ø·~²£¾Çpµe(F) | 2017/01/01 | 2017/12/31 | ¥D«ù¤H |
106 | ¹B¥Î³J¥Õ½èÅé¾Ç±´°QµUÀYµßµßµ·Åéµo»Ãª«§í¨î¤j¸zÀù¤§¼Ð¹v³J¥Õ¥\¯à»PªíÆ[¿ò¶Ç½Õ±±ªº¬ÛÃö©Ê¾÷¨î¬ã¨s(3/3) | °ê¬ì·|±MÃD¬ã¨spµe(D1) | 2017/08/01 | 2018/07/31 | ¥D«ù¤H |
106 | Ua¯à¶q°·±d¤ì»s«~¹ï°ª¦åÀ£±wªÌªººÎ¯v»Ùê»P¥Í¬¡«~½èÁ{§É¸ÕÅçp¹º | ¥ø·~²£¾Çpµe(F) | 2017/10/01 | 2018/09/30 | ¥D«ù¤H |
106 | ±´°Q¤ú©P¯f·P¬V¦åºÞ²ÓM½Õ±±TLR¤Îintegrin°T®§¶Ç»¼³y¦¨°Ê¯ßµw¤Æ¾÷¨î(2/2) | ¥ø·~²£¾Çpµe(F) | 2017/11/01 | 2018/10/31 | ¥D«ù¤H |
106 | µUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¦h¤ÚÓi¯«¸g²ÓM°ö¾i»PµUÀY¯À¹ï¤Úª÷´Ë¤ó¯g°Êª«ªvÀø®ÄªGµû¦ô | ¥ø·~²£¾Çpµe(F) | 2018/01/01 | 2019/12/30 | ¥D«ù¤H |
106 | ¹ñ·s¤ÑµMª«µUÀY¯À¢á§í¨î¤HÃþGÀù²ÓMÂಾ«Iŧ¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¤èªk±´¯ÁµUÀY¯À³J¥Õªí²{¤§¬ã¨s(2/3) | ¥ø·~²£¾Çpµe(F) | 2018/01/01 | 2018/12/31 | ¥D«ù¤H |
107 | ·s«¬µUÀYµß²GºAµo»ÃµÑ¨úª«µUÀY¯À§í¨î¤HÃþGÀù²ÓM¤§¾÷¨î»PªíÆ[¿ò¶Ç½Õ±±¤§¬ã¨s(1/3) | °ê¬ì·|±MÃD¬ã¨spµe(D1) | 2018/08/01 | 2019/07/31 | ¥D«ù¤H |
107 | ¹ñ·s¤ÑµMª«µUÀY¯À¢á§í¨î¤HÃþGÀù²ÓMÂಾ«Iŧ¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¤èªk±´¯ÁµUÀY¯À³J¥Õªí²{¤§¬ã¨s(3/3) | ¥ø·~²£¾Çpµe(F) | 2019/01/01 | 2019/12/31 | ¥D«ù¤H |
107 | ¹B¥Î¬¡Åé¥ú¾Ç¦¨¹³»P³J¥Õ½èÅé¾Ç±´°QÃĥίuµßµUÀY¯À³z¹L PAK¬¡¤Æ¿E酶½Õ¸`°©¬[³J¥Õªº§@¥Î¦Ó§í¨î©¬ª÷´Ë¤ó¯g°Êª«¤§¯«¸g²ÓM·l¶Ë¾÷¨î±´°Q(1/1) | ¥ø·~²£¾Çpµe(F) | 2019/03/01 | 2020/02/29 | ¥D«ù¤H |
107 | «e¤©ÊµUÀYÛ£µßµ·ÅéµÑ¨úª«µUÀY¯À³z¹L PAK1¬¡¤Æ¿E酶¹ïªvÀø¤j¹«³Ð¶Ë©Ê¸£·l¶Ë¤§¬ã¨s | ¬F©²²£¾Çpµe(B) | 2019/06/01 | 2020/05/31 | ¥D«ù¤H |
107 | «e¤©ÊµUÀYÛ£µßµ·ÅéµÑ¨úª«µUÀY¯À³z¹LPAKI¬¡¤Æ¿E酶¹ïªvÀø¤j¹«³Ð¶Ë©Ê¸£·l¶Ë¤§¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2019/06/01 | 2020/05/31 | ¥D«ù¤H |
108 | ·s«¬µUÀYµß²GºAµo»ÃµÑ¨úª«µUÀY¯À§í¨î¤HÃþGÀù²ÓM¤§¾÷¨î»PªíÆ[¿ò¶Ç½Õ±±¤§¬ã¨s(2/3) | °ê¬ì·|±MÃD¬ã¨spµe(D1) | 2019/08/01 | 2020/07/31 | ¥D«ù¤H |
108 | ¤ÑµMª«µÑ¨ú¤p¤À¤lµUÀY¯À´î½w¤j¹«³Ð¶Ë©Ê¸£¾_Àú»¤¾É·L½¦½è²ÓMµoª¢¤§¬ã¨s(1/3) | ¥ø·~²£¾Çpµe(F) | 2019/12/01 | 2020/11/30 | ¥D«ù¤H |
108 | °w¹ï¤p¹«¤â³N©Ê³Ð¶Ë¶Ë¤f¤§¥Ö½§¥\¯à«ì´_¤§¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2020/01/01 | 2021/12/31 | ¥D«ù¤H |
108 | CCLs/CXCLsÁͤƦ]¤l°Ñ»P¸£·L½¦²ÓM¯«¸gµoª¢°h¤Æ¾÷¨î»P³z¹L¤ÑµMÃĪ« erinacine C¹F¨ì§í¨î®ÄªGªº¬ã¨s(1/2) | ¥ø·~²£¾Çpµe(F) | 2020/01/01 | 2020/12/31 | ¥D«ù¤H |
109 | ·s«¬µUÀYµß²GºAµo»ÃµÑ¨úª«µUÀY¯À§í¨î¤HÃþGÀù²ÓM¤§¾÷¨î»PªíÆ[¿ò¶Ç½Õ±±¤§¬ã¨s(3/3) | °ê¬ì·|±MÃD¬ã¨spµe(D1) | 2020/08/01 | 2021/07/31 | ¥D«ù¤H |
109 | ¤ÑµMª«µÑ¨ú¤p¤À¤lµUÀY¯À´î½w¤j¹«³Ð¶Ë©Ê¸£¾_Àú»¤¾É·L½¦½è²ÓMµoª¢¤§¬ã¨s(2/3) | ¥ø·~²£¾Çpµe(F) | 2020/12/01 | 2021/11/30 | ¥D«ù¤H |
109 | CCLs/CXCLsÁͤƦ]¤l°Ñ»P¸£·L½¦²ÓM¯«¸gµoª¢°h¤Æ¾÷¨î»P³z¹L¤ÑµMÃĪ« erinacine C¹F¨ì§í¨î®ÄªGªº¬ã¨s(2/2) | ¨ä¥L³æ¦ì²£¾Çpµe(H) | 2021/01/01 | 2021/12/31 | ¥D«ù¤H |
109 | ¼ÌªÛ¦¨¤À»²§U°§C¤ÆÀø¥ÎÃľ¯¶q¤§¬ã¨s | ¥ø·~²£¾Çpµe(F) | 2021/01/01 | 2022/12/31 | ¥D«ù¤H |
110 | ¹ñ·sµÑ¨úµUÀY¯À§í¨î§ÜÃĩʤj¸zÀù²ÓM«I¥ÇÂಾ»P½Õ±±ªíÆ[¿ò¶Ç¾÷¨î¤§¬ã¨s | °ê¬ì·|±MÃD¬ã¨spµe(D1) | 2021/08/01 | 2022/07/31 | ¥D«ù¤H |
110 | ¬ì§Þ³¡pµe(NMRPF6L0031)¬Û¹ï¸É§U20% | ®Õ¤º¸É§U®×(K) | 2021/08/01 | 1900/01/00 | ¥D«ù¤H |
110 | ¤ÑµMª«µÑ¨ú¤p¤À¤lµUÀY¯À´î½w¤j¹«³Ð¶Ë©Ê¸£¾_Àú»¤¾É·L½¦½è²ÓMµoª¢¤§¬ã¨s(3/3) | ¨ä¥L³æ¦ì²£¾Çpµe(H) | 2021/12/01 | 2022/11/30 | ¥D«ù¤H |
111 | ¹B¥Îªì¥N¸£²ÓM°ö¾i¨Ã±´°Q¤p½¦½è²ÓM§K¬Ì@¨ü¹Lµ{¤¤§Üµoª¢¾÷¨î»P¯«¸g«OÅ@§@¥Î(1/1) | ¨ä¥L³æ¦ì²£¾Çpµe(H) | 2022/07/01 | 2023/06/30 | ¥D«ù¤H |
110 | ¹ñ·sµÑ¨úµUÀY¯À§í¨î§ÜÃĩʤj¸zÀù²ÓM«I¥ÇÂಾ»P½Õ±±ªíÆ[¿ò¶Ç¾÷¨î¤§¬ã¨s(2/3) | °ê¬ì·|±MÃD¬ã¨spµe(D1) | 2022/08/01 | 2023/07/31 | ¥D«ù¤H |
110 | ¬ì§Þ³¡pµe(NMRPF6L0032)¬Û¹ï¸É§U20% | ®Õ¤º¸É§U®×(K) | 2022/08/01 | ¥D«ù¤H | |
110 | °ê¬ì·|²£¾Çpµe(NCRPF6M0011)¬Û¹ï¸É§U50% | ®Õ¤º¸É§U®×(K) | 2022/11/01 | ¥D«ù¤H | |
110 | ¥Í²£²GºAµo»Ã·s¿oµUÀY¯À§í¨î¯«¸gÁͤƦ]¤lCCLs/CXCLsªvÀø¥¢´¼¯g¤§¥Î³~ | ¥ø·~²£¾Çpµe(F) | 2022/11/01 | 2024/10/30 | ¥D«ù¤H |
110 | ¥Í²£²GºAµo»Ã·s¿oµUÀY¯À§í¨î¯«¸gÁͤƦ]¤lCCLs/CXCLs ªvÀø¥¢´¼¯g¤§¥Î³~ | ¬F©²²£¾Çpµe(B) | 2022/11/01 | 2023/10/31 | ¥D«ù¤H |
110 | »OÆWòÔ²GºAµo»ÃµÑ¨úª«¹ï©ó¤j¹«°ª¦åÀ£¤Î¦åºÞ©Ê¥¢´¼¯g¤§«OÅ@§@¥Î¾÷¨î(1/3) | ¨ä¥L³æ¦ì²£¾Çpµe(H) | 2022/12/01 | 2023/11/30 | ¥D«ù¤H |
112 | ¹ñ·sµÑ¨úµUÀY¯À§í¨î§ÜÃĩʤj¸zÀù²ÓM«I¥ÇÂಾ»P½Õ±±ªíÆ[¿ò¶Ç¾÷¨î¤§¬ã¨s(3/3) | °ê¬ì·|±MÃD¬ã¨spµe(D1) | 2023/08/01 | 2024/07/31 | ¥D«ù¤H |
112 | °ê¬ì·|pµe20%-NMRPF6L0033 | ®Õ¤º¸É§U®×(K) | 2023/08/01 | 2024/07/31 | ¥D«ù¤H |
112 | ¬ì´¶¬¡°Ê¡GSTEMºë·Ç°·±d»â°ì¡X¤k©Ê¬ì¾Ç®a±À¼sp¹º(¥DÃD¤T) | ¬F©²¨ä¥L®×¥ó(E) | 2023/08/01 | 2024/07/31 | ¦@¦P(¨ó¦P)¥D«ù¤H |
112 | «Øºc¥þ·s¯«¸g½¦½è²ÓM¦@°ö¾i¼Ò«¬¨Ó±´°Q¸£¤º¥ý¤Ñ§K¬Ì°O¾Ðªº¤À¤l¾÷¨î¡G¤p½¦½è²ÓM§K¬Ì@¨ü»P°V½m§K¬Ì(1/3) | ¨ä¥L³æ¦ì²£¾Çpµe(H) | 2023/08/01 | 2024/07/31 | ¥D«ù¤H |
112 | »OÆWòÔ²GºAµo»ÃµÑ¨úª«¹ï©ó¤j¹«°ª¦åÀ£¤Î¦åºÞ©Ê¥¢´¼¯g¤§«OÅ@§@¥Î¾÷¨î(2/3) | ¨ä¥L³æ¦ì²£¾Çpµe(H) | 2023/12/01 | 2024/11/30 | ¥D«ù¤H |
´Á¥Z½×¤å¦Cªí
|
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I ) |
¦~«× | ©ÒÄÝpµe®× | ½×¤å¦WºÙ | ¦¬¿ý¤ÀÃþ | §@ªÌ¶¶§Ç | ³q°T§@ªÌ | ¥Zª«¦WºÙ | µoªí¨÷¼Æ | µoªí´Á¼Æ | µoªí¤ë¥÷ | µoªí¦~¥÷ |
098 | CMRPF680051 | The proliferation and differentiation of placental-derived multipotent cells into smooth muscle cells on fFibrillar collagen | SCI | ²Ä¤»§@ªÌ | §_ | Biomaterials | 31 | 15 | 05 | 2010 |
100 | CZRPG880252; CMRPF680051; EZRPF390261 | Use of proteomic differential displays to assess functional discrepancies and adjustments of human bone marrow- and Wharton jelly-derived mesenchymal stem cells | SCI | ²Ä¤@§@ªÌ | §_ | Journal of Proteome Research | 10 | 0 | 12 | 2011 |
099 | CZRPG880252¡B CMRPF680051 and EZRPF390261 | Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression | SCI | ²Ä¤§@ªÌ | §_ | J. Cell. Physiol | 9999 | 1-10 | 09 | 2010 |
100 | CZRPG880252¡B CMRPF680052 and EZRPF390261 | Stromal cell-derived factor-1/CXC receptor 4 andƒÒb1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells | SCI | ²Ä¤Q§@ªÌ | ¬O | J. Cell. Physiol | 227 | 3 | 03 | 2012 |
099 | CZRPG880252¡B CMRPF680051 and EZRPF390261 | Baicalein inhibits the migration and invasive properties of human hepatoma cells | SCI | ²Ä¤Q§@ªÌ | ¬O | Toxicol Appl Pharmacol | 255 | 0 | 07 | 2011 |
099 | CZRPG880253, CMRPF680052 and EZRPF390261 | High glucose-treated macrophages augment E-selectin expression in endothelial cells | SCI | ²Ä¤T§@ªÌ | §_ | J Biol Chem | 286 | 29 | 06 | 2011 |
100 | CZRPG880252¡B CMRPF680051 and EZRPF390261 | Proteomic Analysis of the Effects of Baicalein on Colon-rectal Cancer Cells | SCI | ²Ä¤@§@ªÌ | ¬O | Proteomics | 12 | 6 | 03 | 2012 |
100 | CZRPG880252¡B CMRPF680051 and EZRPF390261 | Regulation of cyclooxygenase-2 expression in human bladder epithelial cells infected with type I fimbriated Uropathogenic E. coli. | SCI | ²Ä¤»§@ªÌ | §_ | Cell Microbiol | 13 | 11 | 10 | 2011 |
100 | CMRPF 680051, CMRPF 680052, EZRPF 6A0021 and EZRPF 390261 | Identification of immunodeficient molecules in neonatal mononuclear cells by proteomics differential displays. | SCI | ²Ä¤G§@ªÌ | §_ | Proteomics | 11 | 0 | 10 | 2011 |
101 | CZRPG880252¡BCMRPF680051 and EZRPF390261 | CXC chemokine ligand 12/Stromal cell-derived factor-1 regulates cell adhesion in human colon cancer | SCI | ²Ä¤C§@ªÌ | §_ | J Biomed Sci | 19 | Open | 10 | 2012 |
101 | CZRPG880252¡BCMRPF680051 and EZRPF390261 | The Inhibitory effect of CIL-102 on the growth of human astrocytoma cells is mediated by the generation of reactive oxygen species and induction of ERK1/2 MAPK | SCI | ²Ä¤G§@ªÌ | §_ | Toxicol Appl Pharmacol | 263 | 1 | 08 | 2012 |
101 | µL | Shear stress modulates macrophage-induced urokinase plasminogen activator expression in human chondrocytes | SCI | ²Ä¤§@ªÌ | §_ | Arthritis research & therapy | 15 | Open | 04 | 2013 |
102 | CMRPF6A0072 | Inhibitory effect of liposome-encapsulated anthocyanin on melanogenesis in human melanocytes. | SCI | ²Ä¤G§@ªÌ | §_ | Pharmaceutical Biology | 51 | 8 | 08 | 2013 |
101 | CZRPG880253, CMRPF6A0072, CMRPF6C0031, EZRPF6C0011 and NSC101-2622-B-255-001-CC3 | Glycyrrhizin Represses Total Parenteral Nutrition-Associated Acute Liver Injury in Rats by Suppressing Endoplasmic Reticulum Stress | SCI | ²Ä¤G§@ªÌ | §_ | International Journal of Molecular Sciences | 14 | 6 | 06 | 2013 |
102 | CZRPG880253, CMRPF6A0072, CMRPF6C0031, EZRPF6C0011 and NSC101-2622-B-255-001-CC3 | Regulation of ICAM-1 expression in gingival fibroblasts infected with high-glucose-treated P. gingivalis | SCI | ²Ä¤@§@ªÌ | ¬O | Cellular Microbiology | 15 | 10 | 10 | 2013 |
102 | CZRPG880253, CMRPF6A0072, CMRPF6C0031, EZRPF6C0011 and NSC101-2622-B-255-001-CC3 | Quantitative proteomic analysis of the inhibitory effects of CIL-102 on viability and invasiveness in human glioma cells | SCI | ²Ä¤G§@ªÌ | §_ | Toxicology and Applied Pharmacology | 272 | 3 | 11 | 2013 |
102 | µL | The protective effect of luteolin on cytotoxicity and genotoxicity of bisphenol-A-glycidyldimethacrylate in macrophages involved in DNA damage and caspases activation | SCI | ²Ä¤§@ªÌ | ¬O | Life Science Journal | 10 | 4 | 12 | 2013 |
102 | CMRPF6A0073, CMRPF6C0031, EZRPF6C0011 NSC101-2622-B-255-001-CC3 and NSC102-2313-B-255-002 | Exploring the effects of tert-butylhydroperoxide induced liver injury using proteomic approach | SCI | ²Ä¤Q§@ªÌ | ¬O | Toxicology | 316 | 0 | 02 | 2014 |
102 | CMRPF6C0032¡BCMRPF6A0073¡BNSC101-2622-B-255-001-CC3¡BNSC102-2313-B-255-002 and 103-2622-B-255-001-CC3 | Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFkappaB signaling pathway in gastric cancer cells. | SCI | ²Ä¤Q§@ªÌ | ¬O | J Biomed Sci. | 21 | 1 | 06 | 2014 |
102 | CMRPF6A0073¡BCMRPF6C0032¡BEZRPF6C0011, NSC101-2622-B-255-001-CC3, NSC102-2313-B-255-002 and MOST103-2622-B-255-001-CC3 | Activation of neutral-sphingomyelinase, MAPKs, and p75 NTR-mediating caffeic acid phenethyl ester-induced apoptosis in C6 glioma cells. | SCI | ²Ä¤C§@ªÌ | ¬O | J Biomed Sci. | 21 | 1 | 07 | 2014 |
103 | CMRPG6C0072, CMRPF6A0073,CMRPF6C0032,,NSC101-2622-B-255-001-CC3, NSC102-2313-B-255-002 and MOST103-2622-B-255-001-CC3 | Protective Effects of Hericium erinaceus Mycelium and Its Isolated Erinacine A against Ischemia-Injury-Induced Neuronal Cell Death via the Inhibition of iNOS/p38 MAPK and Nitrotyrosine | SCI | ²Ä¤Q§@ªÌ | ¬O | Int. J. Mol. Sci. | 15 | 0 | 08 | 2014 |
103 | CMRPF6A0073¡BCMRPF6C0032¡BNSC101-2622-B-255-001-CC3¡BNSC102-2313-B-255-002 | Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine. | SCI | ²Ä¤G§@ªÌ | §_ | Toxicol Appl Pharmacol. | 279 | 3 | 09 | 2014 |
103 | CMRPF6A0073¡BCMRPF6C0032¡BNSC101-2622-B-255-001-CC3¡BNSC102-2313-B-255-002¡B MOST103-2622-B-255-001-CC3 | Upregulation of TLRs and IL-6 as a marker in human colorectal cancer. | SCI | ²Ä¤G§@ªÌ | §_ | Int J Mol Sci. | 16 | 1 | 12 | 2014 |
103 | µL | Ethyl acetate extract of Wedelia chinensis inhibits tert-butyl hydroperoxide-induced damage in PC12 cells and D-galactose-induced neuronal cell loss in mice. | SCI | ²Ä¥|§@ªÌ | §_ | BMC Complement Altern Med. | 14 | 1 | 12 | 2014 |
103 | CMRPF6A0073, EZRPF6C0011, NSC101-2622-B-255-001-CC3 and NSC102-2313-B-255-002 | Differential regulation of human aortic smooth muscle cell proliferation by monocyte-derived macrophages from diabetic patients. | SCI | ²Ä¤T§@ªÌ | §_ | PLoS One. | 9 | 11 | 11 | 2014 |
103 | CZRPG880253, CMRPF6A0073, NSC101-2622-B-255-001-CC3 and NSC102-2313-B-255-002 | Interleukin-17 induces CC chemokine receptor 6 expression and cell migration in colorectal cancer cells. | SCI | ²Ä¤T§@ªÌ | §_ | J. Cell. Physiol. | Accepted. | Accepted. | 09 | 2014 |
103 | CMRPF6E0011¡BCMRPE0041¡BCMRPE0021¡BMOST103-2622-B-255-001-CC3¡B MOST103-2313-B-255-001 | Global proteomic analysis of brain tissues in transient ischemia brain damage in rats. | SCI | ²Ä¤G§@ªÌ | §_ | International Journal of Molecular Sciences | 16 | 6 | 05 | 2015 |
103 | CMRPF6E0021, CMRPF6E0011, NSC101-2622-B-255-001-CC3 and NSC102-2313-B-255-002 | Fulvic acid attenuates homocysteine-induced cyclooxygenase-2 expression in human monocytes. | SCI | ²Ä¤T§@ªÌ | §_ | BMC Complementary and Alternative Medicine | 15 | 0 | 03 | 2015 |
104 | CMRPF6E0011, CMRPF6E0021, MOST101-2622-B-255-001-CC3 and MOST102-2313-B-255-002 | Shear stress modulates resistin-induced CC chemokine ligand 19 expression in human aortic endothelial cells. | SCI | ²Ä¤T§@ªÌ | §_ | Journal of Cellular Physiology | 230 | 9 | 09 | 2015 |
103 | CMRPF6A0073,CMRPF6C0032 | Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array. | SCI | ²Ä¤T§@ªÌ | §_ | Arthritis & Rheumatology | 67 | 3 | 03 | 2015 |
104 | µL | Upregulation of Bone Morphogenetic Protein-2 Synthesis and Consequent Collagen II Expression in Leptin-stimulated Human Chondrocytes. | SCI | ²Ä¤»§@ªÌ | §_ | PLoS One. | 10 | 12 | 12 | 2015 |
104 | CMRPF6E0011, CMRPF6E0041, CMRPF6E0021, MOST 103-2622-B-255-001-CC3,MOST 103-2313-B-255-001 and MOST 104-2320-B-255-003-MY3 | Proteomic analysis of plasma from rats following total parenteral nutrition-induced liver injury. | SCI | ²Ä¤G§@ªÌ | §_ | Proteomics. | 15 | 22 | 11 | 2015 |
104 | CMRPF6E0041 | Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients. | SCI | ²Ä¤E§@ªÌ | §_ | Int J Mol Sci. | 17 | 5 | 05 | 2016 |
104 | µL | Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease. | SCI | ²Ä¤K§@ªÌ | §_ | PLoS One. | 11 | 5 | 05 | 2016 |
104 | CMRPF6E0041 | Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease. | SCI | ²Ä¤»§@ªÌ | §_ | Medicine (Baltimore). | 95 | 17 | 04 | 2016 |
104 | BMRPD42, CMRPF6E0011, CMRPF6E0041,CMRPF6E0021, MOST 103-2622-B-255-001-CC3 and MOST 103-2313-B-255-001 and MOST 104-2320-B-255 -003 -MY3 | Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade. | SCI | ²Ä¤@§@ªÌ | §_ | J Transl Med. | 14 | 0 | 03 | 2016 |
104 | CMRPF6E0011, CMRPF6E0041, CMRPF6E0021, MOST 103-2622-B-255-001-CC3,MOST 103-2313-B-255-001 | Inhibitory effect of Erinacines A on the growth of DLD-1 colorectal cancer cells is induced by generation of reactive oxygen species and activation of p70S6K and p21 | SCI | ²Ä¤Q¤@§@ªÌ¥H¤W | ¬O | J Funct Foods. | 21 | 0 | 03 | 2016 |
105 | CMRPF6E0041 | Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease. | SCI | ²Ä¤C§@ªÌ | §_ | BMC Med Genomics. | 9 Suppl 1 | 0 | 08 | 2016 |
105 | BMRPD42, CMRPF6E0011, CMRPF6E0021, CMRPF6E0041, MOST 104-2320-B-255 -003 -MY3. | Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo. | SCI | ²Ä¤K§@ªÌ | ¬O | J Transl Med. | 14 | 0 | 09 | 2016 |
105 | BMRPD42, CMRPF6E0011, CMRPF6E0041, CMRPF6E0021, MOST104-2320-B-255-003-MY3. | The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells. | SCI | ²Ä¤Q¤@§@ªÌ¥H¤W | ¬O | PLoS One. | 11 | 0 | 09 | 2016 |
105 | BMRPD42, CMRPF6C0032, CMRPF6F0031, CMRPF6E0041, CMRPF6E0021, MOST104-2320-B-255-003-MY3. | Sterol Regulatory Element-Binding Protein-1c Regulates Inflammasome Activation in Gingival Fibroblasts Infected with High-Glucose-Treated Porphyromonas gingivalis. | SCI | ²Ä¤@§@ªÌ | §_ | Front Cell Infect Microbiol. | 6 | 0 | 12 | 2016 |
105 | CMRPF6E0011, CMRPF6E0041, CMRPF6E0021, MOST 103-2622-B-255-001-CC3, MOST 103-2313-B-255-001 and MOST 104-2320-B-255 -003 -MY3 | A proteomics approach to identifying novel protein targets involved in erinacine A-mediated inhibition of colorectal cancer cells' aggressiveness. | SCI | ²Ä¤G§@ªÌ | §_ | Journal of Cellular and Molecular Medicine | 21 | 3 | 03 | 2017 |
106 | CMRPF6F0031,CMRPF6G0011, MOST 103-2622-B-255-001-CC3 and MOST 103-2313-B-255-001 and MOST 104-2320-B-255 -003 -MY3 | A Comparative Proteomic Analysis of Erinacine A's Inhibition of Gastric Cancer Cell Viability and Invasiveness. | SCI | ²Ä¤@§@ªÌ | §_ | CELLULAR PHYSIOLOGY AND BIOCHEMISTRY | 43 | 1 | 08 | 2017 |
105 | CMRPF6E0041 | Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease. | SCI | ²Ä¤»§@ªÌ | §_ | BMC Pharmacol Toxicol | 18 | 1 | 01 | 2017 |
105 | CMRPF6D0071, CMRPF6D0072, CMRPF6D0073 | CIL-102-Induced Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells via Upregulation of p21 and GADD45. | SCI | ²Ä¤T§@ªÌ | §_ | PLoS One. | 12 | 1 | 01 | 2017 |
106 | CMRPF6E0041 | HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease. | SCI | ²Ä¤@§@ªÌ | §_ | J Mol Cell Cardiol. | 117 | 0 | 03 | 2018 |
106 | µL | Protective effect of black garlic extracts on tert-Butyl hydroperoxide-induced injury in hepatocytes via a c-Jun N-terminal kinase-dependent mechanism. | SCI | ²Ä¤»§@ªÌ | §_ | Exp Ther Med. | 15 | 3 | 03 | 2018 |
106 | CMRPF6G0011 | Comparative Proteomic Identification of Protein Disulphide Isomerase A6 Associated with Tert-Butylhydroperoxide-Induced Liver Injury in Rat Hepatocytes. | SCI | ²Ä¤K§@ªÌ | ¬O | Cell Physiol Biochem. | 45 | 5 | 03 | 2018 |
107 | BMRPD42, CMRPF6G0011,CMRPF6G0012, CMRPF6G0013, MOST 107-2320-B-255 -001 -MY3 | Expression of PRDX6 Correlates with Migration and Invasiveness of Colorectal Cancer Cells. | SCI | ²Ä¤Q¤@§@ªÌ¥H¤W | ¬O | Cell Physiol Biochem. | 51 | 6 | 12 | 2018 |
106 | µL | Prescription patterns of traditional Chinese medicine amongst Taiwanese children: a population-based cohort study. | SCI | ²Ä¥|§@ªÌ | §_ | BMC Complement Altern Med. | 18 | 0 | 01 | 2018 |
107 | µL | MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation. | SCI | ²Ä¤G§@ªÌ | §_ | Int J Med Sci. | 16 | 2 | 01 | 2019 |
108 | BMRPD42,MRPF6G0011, CMRPF6G0012, CMRPF6G0013, CMRPF6I0021 | Induction Apoptosis of Erinacine A in Human Colorectal Cancer Cells Involving the Expression of TNFR, Fas, and Fas Ligand via the JNK/p300/p50 Signaling Pathway With Histone Acetylation | SCI | ²Ä¤Q¤@§@ªÌ¥H¤W | ¬O | Front Pharmacol | 10 | 0 | 10 | 2019 |
107 | µL | MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice | SCI | ²Ä¤G§@ªÌ | §_ | Int J Mol Sci | 20 | 6 | 03 | 2019 |
108 | BMRPD42 | Properties of N-Type GaN Thin Film with Si-Ti Codoping on a Glass Substrate | SCI | ²Ä¤§@ªÌ | ¬O | CRYSTALS | 10 | 7 | 07 | 2020 |
108 | BMRPD42, CLRPG8G0591, CMRPG6H0031,CMRPG6H0032, CMRPF6G0011, CMRPF6G0012, CMRPF6G0013,CMRPF6I0021 and MOST 108-2622-B-255-001-CC3 and MOST 107-2320-B-255-001-MY3 | Post-Treatment with Erinacine A, a Derived Diterpenoid of H. erinaceus, Attenuates Neurotoxicity in MPTP Model of Parkinson's Disease | SCI | ²Ä¤Q¤@§@ªÌ¥H¤W | ¬O | Antioxidants (Basel). | 9 | 2 | 01 | 2020 |
109 | µL | Type II Collagen from Cartilage of Acipenser baerii Promotes Wound Healing in Human Dermal Fibroblasts and in Mouse Skin | SCI | ²Ä¤T§@ªÌ | §_ | Mar Drugs. | 18 | 10 | 10 | 2020 |
109 | BMRPD42, CLRPG8G0591, CMRPF6H0011, CMRPF6H0012, CMRPF6H0013, CMRPF6J0081, CMRPF6K0071, MOST 107-2320-B-255 -001 -MY3 and MOST 108-2622-B-255-001-CC3 | Novel regulator role of CIL-102 in the epigenetic modification of TNFR1/TRAIL to induce cell apoptosis in human gastric cancer | SCI | ²Ä¤Q§@ªÌ | ¬O | FOOD AND CHEMICAL TOXICOLOGY | 147 | 0 | 01 | 2021 |
109 | µL | Investigation of Zn/Sn ratio for improving the material quality of CZTS thin films with the reduction of Cu2-xS secondary phase | SCI | ²Ä¤§@ªÌ | ¬O | JOURNAL OF ALLOYS AND COMPOUNDS | 0 | 0 | 09 | 2020 |
110 | µL | Investigation of Cu2ZnSnS4 thin film with preannealing process and ZnS buffer layer prepared by magnetron sputtering deposition. | SCIE | ²Ä¤§@ªÌ | ¬O | JOURNAL OF ALLOYS AND COMPOUNDS | 884 | 0 | 12 | 2021 |
109 | CMRPF6G0011, CMRPF6G0012, CMRPF6G0013, CMRPF6I0021, CMRPF6J0081 and CMRPF6K0071 | Apoptotic mechanisms of gastric cancer cells induced by isolated erinacine S through epigenetic histone H3 methylation of FasL and TRAIL | SCIE | ²Ä¤Q¤@§@ªÌ¥H¤W | ¬O | FOOD & FUNCTION | 12 | 8 | 04 | 2021 |
110 | MOST 110-2320-B-255 -005 -MY3 | Ailanthoidol, a Neolignan, Suppresses TGF-beta 1-Induced HepG2 Hepatoblastoma Cell Progression | SCIE | ²Ä¤»§@ªÌ | ¬O | BIOMEDICINES | 9 | 9 | 09 | 2021 |
109 | µL | Enhanced antioxidant activity of Chenopodium formosanum Koidz. by lactic acid bacteria: Optimization of fermentation conditions | SCIE | ²Ä¤@§@ªÌ | §_ | PLOS ONE | 16 | 5 | 05 | 2021 |
109 | µL | Improvement of device characteristics of plasma-treated indium gallium zinc oxide thin-film transistors through thermal annealing | SCIE | ²Ä¤§@ªÌ | ¬O | SEMICONDUCTOR SCIENCE AND TECHNOLOGY | 36 | 4 | 04 | 2021 |
109 | MOST 110-2320-B-255 -005 -MY3 | Improving Device Characteristics of Dual-Gate IGZO Thin-Film Transistors with Ar-O-2 Mixed Plasma Treatment and Rapid Thermal Annealing | SCI, SCIE | ²Ä¤§@ªÌ | ¬O | MEMBRANES | 12 | 1 | 01 | 2022 |
110 | MOST 110-2320-B-255 -005 -MY3. | Ganoderma formosanum Exopolysaccharides Inhibit Tumor Growth via Immunomodulation | SCIE | ²Ä¤@§@ªÌ | §_ | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 22 | 20 | 10 | 2021 |
110 | MOST 107-2320-B-255 -001 -MY3 | Identification of Two Novel CIL-102 Upregulations of ERP29 and FUMH to Inhibit the Migration and Invasiveness of Colorectal Cancer Cells by Using the Proteomic Approach | SCIE | ²Ä¤G§@ªÌ | §_ | Biomolecules | 11 | 9 | 09 | 2021 |
109 | µL | Enzymatic degradation of ginkgolic acids by laccase immobilized on core/shell Fe3O4/nylon composite nanoparticles using novel coaxial electrospraying process | SCIE | ²Ä¤T§@ªÌ | §_ | INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES | 172 | 0 | 03 | 2021 |
111 | µL | Optimal Growth Conditions for Forming c-Axis (002) Aluminum Nitride Thin Films as a Buffer Layer for Hexagonal Gallium Nitride Thin Films Produced with In Situ Continual Radio Frequency Sputtering | SCIE | ²Ä¤C§@ªÌ | ¬O | MICROMACHINES | 13 | 9 | 09 | 2022 |
110 | MOST 110-2320-B-255-005-MY3 | 2D-DIGE-MS Proteomics Approaches for Identification of Gelsolin and Peroxiredoxin 4 with Lymph Node Metastasis in Colorectal Cancer | SCIE | ²Ä¤K§@ªÌ | ¬O | CANCERS | 14 | 13 | 06 | 2022 |
110 | MOST 110-2320-B-255 -005 -MY3 | Suppression of the Proliferation of Huh7 Hepatoma Cells Involving the Downregulation of Mutant p53 Protein and Inactivation of the STAT 3 Pathway with Ailanthoidol | SCIE | ²Ä¤K§@ªÌ | ¬O | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 23 | 9 | 05 | 2022 |
110 | CMRPF6K0071, CMRPF6K0072, ZRRPF6L0011 | Neuron-Microglia Contacts Govern the PGE(2) Tolerance through TLR4-Mediated de Novo Protein Synthesis | SCIE | ²Ä¤@§@ªÌ | §_ | BIOMEDICINES | 10 | 2 | 02 | 2022 |
110 | BMRPD42, CMRPF6J0081,CMRPF6J0082, CMRPF6K0071, and CMRPF6K0072 | Identification of early response to hypertonic dextrose prolotherapy markers in knee osteoarthritis patients by an inflammation-related cytokine array | SCIE | ²Ä¥|§@ªÌ | ¬O | JOURNAL OF THE CHINESE MEDICAL ASSOCIATION | 85 | 4 | 04 | 2022 |
111 | µL | Si¡VSn codoped n-GaN film sputtering grown on an amorphous glass substrate | SCIE | ²Ä¤§@ªÌ | ¬O | SEMICONDUCTOR SCIENCE AND TECHNOLOGY | 38 | 7 | 05 | 2023 |
111 | BMRPD42,MOST 110-2320-B-255-005-MY3 | Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma | SCI, SCIE | ²Ä¤E§@ªÌ | ¬O | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 27 | 14 | 06 | 2023 |
111 | BMRPD42, CMRPF6L0061, CMRPF6L0062, CMRPF6L0063, ZRRPF6M0011, CMRPF6M0071, CMRPF6M0072, CMRPF6M0073, MOST 110-2320-B-255 -005 -MY3 | Antrodin C Isolated from Antrodia Cinnamomea Induced Apoptosis through ROS/AKT/ERK/P38 Signaling Pathway and Epigenetic Histone Acetylation of TNF£\ in Colorectal Cancer Cells | SCI, SCIE | ²Ä¤Q¤@§@ªÌ¥H¤W | ¬O | Antioxidants | 12 | 3 | 03 | 2023 |
112 | µL | Tolerized Microglia Protect Neurons Against Endotoxin-Induced TNF-£\ Production via an LBP-Dependent Intracellular p38 MAPK Signaling Pathway | SCIE | ²Ä¤@§@ªÌ | ¬O | Inflammation | 46 | 5 | 10 | 2023 |
¬ã°Q·|½×¤å¦Cªí
|
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I ) |
¦~«× | ©ÒÄÝpµe®× | ½×¤å¦WºÙ | §@ªÌ¶¶§Ç | ³q°T§@ªÌ | ¬ã°Q·|¦WºÙ | Á|¦æ°ê®a | Á|¦æ«°¥« | ¶}©l¤é´Á | µ²§ô¤é´Á | µoªí¦~¥÷ |
097 | TCVGH-973701A (2/3) | Baicalein Inhibits Invasion of Human Hepatoma Cell Line, Through the Downregulation of MMP-9, MMP2 and NF-£eB, and Proliferation in Vivo | ²Ä¤@§@ªÌ | ¬O | ¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| | ¥xÆW¡A¤¤µØ¥Á°ê | Taipei | 2009/03/21 | 2009/03/22 | 2009 |
101 | µL | Resistin-induced expression of SDF-1 through coordinated activation of p38 MAPK and NF kappaB in gastric epithelial carcinoma | ²Ä¤§@ªÌ | ¬O | The twenty eighth Joint Annual Conference of Biomedical Sciences | ¥xÆW¡A¤¤µØ¥Á°ê | Taipei | 2013/03/23 | 2013/03/24 | 2013 |
101 | µL | Differential Proteomic Display of Mesenchymal Stem Cells Characterizes transgelin-2 and Hsp90ƒÒ as Required Regulation of Proliferation and Differentiation | ²Ä¤@§@ªÌ | ¬O | International Bone and Mineral Society and The Japanese Society for Bone and Mineral Research | ¤é¥» | Kobe | 2013/05/28 | 2013/06/01 | 2013 |
102 | µL | The Inhibitory Effect of Erinacine A From Hericium Erinaceus Mushroom Extracts on The Growth of Human Colorectal Cancer Cells. | ²Ä¤»§@ªÌ | ¬O | The twenty ninth Joint Annual Conference of Biomedical Sciences | ¥xÆW¡A¤¤µØ¥Á°ê | ¥x¥_ | 2014/03/15 | 2014/03/16 | 2014 |
102 | µL | Developed 5-Fu and Oxaliplatin chemoresistant human colorectal cancer stem cells and identification of the molecular mechanism in tumorigenesis. | ²Ä¥|§@ªÌ | ¬O | The twenty ninth Joint Annual Conference of Biomedical Sciences | ¥xÆW¡A¤¤µØ¥Á°ê | ¥x¥_ | 2014/03/15 | 2014/03/16 | 2014 |
102 | µL | Hericium Erinaceus, a Traditional Herbal Formula, Inhibits Cell Proliferation by Induction of Apoptosis in Human Liver Cancer Cells. | ²Ä¤»§@ªÌ | ¬O | The twenty ninth Joint Annual Conference of Biomedical Sciences. | ¥xÆW¡A¤¤µØ¥Á°ê | ¥x¥_ | 2014/03/15 | 2014/03/16 | 2014 |
102 | µL | Exploring the effects of tert-butylhydroperoxide induced liver injury using proteomic approach. | ²Ä¥|§@ªÌ | ¬O | World Academy of Science , Engineering And Technology (WASET) | ¤é¥» | ªF¨Ê | 2014/05/29 | 2014/05/30 | 2014 |
µoªí±M®Ñ¦Cªí
|
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I ) |
¦~«× | ©ÒÄÝpµe®× | ±M®ÑÃþ§O | ±M®Ñ¦WºÙ | §@ªÌ¶¶§Ç | ³q°T§@ªÌ | ¨Ï¥Î»y¤å | ¥Xª©¤é´Á | ¥Xª©ªÀ | ISBN½s¸¹ |
|
>>> ¬ÛÃö¸ê®Æ¤£¤½¶} <<<
|
±M§Q/·s«~ºØ¦Cªí
|
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I ) |
¦~«× | ©ÒÄÝpµe®× | ±M§Q/·s«~ºØ¦WºÙ | °Ï°ì | Ãþ«¬ | §@ªÌ¶¶§Ç |
104 | µL | ÂIºw«O·Å¸Ë¸m | °ê¤º | ·s«¬±M§Q | ²Ä¤G§@ªÌ |
104 | µL | ¨ãµµ¥~½u±j«×«ü¥Ü¥\¯àªº¤Æ§©«~®e¾¹ | °ê¤º | ·s«¬±M§Q | ²Ä¤G§@ªÌ |
104 | µL | ¨¾Å@¦ç | °ê¤º | ·s«¬±M§Q | ²Ä¤@§@ªÌ |
104 | µL | ¯f©Ð§Y®É©I±Ï¸Ë¸m | °ê¤º | ·s«¬±M§Q | ²Ä¤@§@ªÌ |
105 | µL | ¦w¥þ°wµ© | °ê¤º | ·s«¬±M§Q | ²Ä¤K§@ªÌ |
107 | ¦w¥þ°w¨ã | °ê¤º | ·s«¬±M§Q | ²Ä¤@§@ªÌ | |
109 | µL | ¦Õ·Å®M²° | °ê¤º | µo©ú±M§Q | ²Ä¤@§@ªÌ |
109 | µL | ª`®g°wµ© | °ê¤º | µo©ú±M§Q | ²Ä¤@§@ªÌ |
109 | µL | §l¤J©Ê¼QÃú¾¹ | °ê¤º | µo©ú±M§Q | ²Ä¤@§@ªÌ |
110 | µL | ¯ÝºÞ³¬Âê¸Ë¸m | °ê¤º | µo©ú±M§Q | ²Ä¤@§@ªÌ |
112 | µL | ½¦±a¸Ë¸m | °ê¤º | µo©ú±M§Q | ²Ä¤@§@ªÌ |
Àò¹{¼ú¶µ»PºaÅA¦Cªí
|
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I ) |
¦~«× | ©ÒÄÝpµe®× | ¦WºÙ | °ê§O | ¾÷ºc¦WºÙ | ¤é´Á |
||||
098 | CMRPF680051 | Âå¾Ç¬ã¨s½×¤å¼ú Poster Award | ¥xÆW¡A¤¤µØ¥Á°ê | Taiwan Proteomics Society | 2010/04/24 | ||||
100 | µL | 99¾Ç¦~«×ªø©°¬ì§Þ¤j¾Ç¬ã¨sÁZÀu±Ð®v | ¥xÆW¡A¤¤µØ¥Á°ê | ªø©°¬ì§Þ¤j¾Ç | 2011/09/23 | ||||
102 | µL | 101¾Ç¦~«×²£¾Ç¦X§@§Þ³N¬ãµoÁZÀu±Ð®v¼ú | ¥xÆW¡A¤¤µØ¥Á°ê | ªø©°¬ì§Þ¤j¾Ç | 2013/09/26 | ||||
104 | µL | 103¾Ç¦~«×²£¾Ç¦X§@§Þ³N¬ãµoÁZÀu¼ú | ¥xÆW¡A¤¤µØ¥Á°ê | ªø©°¬ì§Þ¤j¾Ç | 2015/09/28 | ||||
106 | µL | 105¾Ç¦~«×ªø©°¬ì§Þ¤j¾Ç²£¾Ç¦X§@§Þ³N¬ãµoÁZÀu±Ð®v¼ú | ¥xÆW¡A¤¤µØ¥Á°ê | ªø©°¬ì§Þ¤j¾Ç | 2017/09/28 | ||||
107 | µL | ªø©°¬ì§Þ¤j¾Ç106¾Ç¦~«×¾Ç³N§@«~µoªíÁZÀu¼ú | ¥xÆW¡A¤¤µØ¥Á°ê | ªø©°¬ì§Þ¤j¾Ç | 2018/09/28 |
±Ð®v§Þ³N²¾Âà©Î±ÂÅv¦Cªí
|
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I ) |
¾Ç¦~«× | §Þ³N²¾Âà©Î±ÂÅv | §ÞÂà©Î±ÂÅv¦WºÙ | §Þ³N²¾Âà©Î±ÂÅv¼t°Ó¦WºÙ | §Þ³N²¾Âàª÷ÃB©Î±ÂÅvª÷ÃB | §Þ³N²¾Âà©Î±ÂÅv°_©l¤é´Á | §Þ³N²¾Âà©Î±ÂÅv²×¤î¤é´Á | §Þ³N²¾Âà©Î±ÂÅv¦X¬ù½s¸¹ | ¬O§_¨ú±o±M§Q | ±M§QÃҮѦr¸¹ |
101 | §Þ³N²¾Âà | ¶}µoµUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¤j¹«¯Ê¦å©Ê¸£¤¤·ªº«OÅ@¾÷Âध¬¡©Ê | ¸²µå¤ý¥Í§ÞªÑ¥÷¦³¤½¥q | 100000 | 20121101 | 20131031 | NCRPF6B0011 | §_ | |
102 | §Þ³N²¾Âà | µUÀYÛ£µßµ·ÅéµÑ¨úª«½Õ¸`¤º½èºôÀ£¤O°T¸¹¹ï¤Úª÷´Ë¤ó¯g°Êª«¯«¸g¤¸Ãa¦º¤Î¦æ¬°¯Ê³´¤§«OÅ@¾÷Âध¬ã¨s | ¸²µå¤ý¥Í§ÞªÑ¥÷¦³¤½¥q | 100000 | 20140601 | 20150531 | NCRPF6D0011 | §_ |